JPS6136830B2 - - Google Patents
Info
- Publication number
- JPS6136830B2 JPS6136830B2 JP57016176A JP1617682A JPS6136830B2 JP S6136830 B2 JPS6136830 B2 JP S6136830B2 JP 57016176 A JP57016176 A JP 57016176A JP 1617682 A JP1617682 A JP 1617682A JP S6136830 B2 JPS6136830 B2 JP S6136830B2
- Authority
- JP
- Japan
- Prior art keywords
- indolyl
- amino
- propionyloxy
- hydroxy
- acetic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims abstract description 9
- 125000004432 carbon atom Chemical group C* 0.000 claims abstract description 9
- 150000003839 salts Chemical class 0.000 claims abstract description 7
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims abstract description 4
- 239000003814 drug Substances 0.000 claims abstract description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical group CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 51
- -1 Ethyl D,L-2-[3-(5-hydroxy-3-indolyl)-2-amino-propionyloxy]acetic acid Chemical compound 0.000 claims description 38
- 150000001875 compounds Chemical class 0.000 claims description 32
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 claims description 32
- 229940076279 serotonin Drugs 0.000 claims description 12
- 238000000034 method Methods 0.000 claims description 11
- 210000004556 brain Anatomy 0.000 claims description 10
- 238000004519 manufacturing process Methods 0.000 claims description 9
- 125000003118 aryl group Chemical group 0.000 claims description 7
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 claims description 7
- 239000002253 acid Substances 0.000 claims description 6
- 125000003277 amino group Chemical group 0.000 claims description 6
- 241001465754 Metazoa Species 0.000 claims description 5
- 150000001242 acetic acid derivatives Chemical class 0.000 claims description 5
- 239000003153 chemical reaction reagent Substances 0.000 claims description 5
- SNRUBQQJIBEYMU-UHFFFAOYSA-N Dodecane Natural products CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 claims description 4
- 238000010511 deprotection reaction Methods 0.000 claims description 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 4
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 claims description 4
- 125000000217 alkyl group Chemical group 0.000 claims description 3
- 239000000010 aprotic solvent Substances 0.000 claims description 3
- 125000006239 protecting group Chemical group 0.000 claims description 3
- 239000004215 Carbon black (E152) Substances 0.000 claims description 2
- 125000001931 aliphatic group Chemical group 0.000 claims description 2
- 238000010531 catalytic reduction reaction Methods 0.000 claims description 2
- 238000009833 condensation Methods 0.000 claims description 2
- 230000005494 condensation Effects 0.000 claims description 2
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 2
- 229940079593 drug Drugs 0.000 claims description 2
- 229930195733 hydrocarbon Natural products 0.000 claims description 2
- 150000002430 hydrocarbons Chemical class 0.000 claims description 2
- 125000001183 hydrocarbyl group Chemical group 0.000 claims 2
- UQDJGEHQDNVPGU-UHFFFAOYSA-N serine phosphoethanolamine Chemical compound [NH3+]CCOP([O-])(=O)OCC([NH3+])C([O-])=O UQDJGEHQDNVPGU-UHFFFAOYSA-N 0.000 claims 2
- HJYGWLFMHCJRJG-UHFFFAOYSA-N 2-propanoyloxyacetic acid Chemical compound CCC(=O)OCC(O)=O HJYGWLFMHCJRJG-UHFFFAOYSA-N 0.000 claims 1
- 230000032050 esterification Effects 0.000 claims 1
- 238000005886 esterification reaction Methods 0.000 claims 1
- 230000001681 protective effect Effects 0.000 claims 1
- 230000007812 deficiency Effects 0.000 abstract description 2
- HZVOZRGWRWCICA-UHFFFAOYSA-N methanediyl Chemical compound [CH2] HZVOZRGWRWCICA-UHFFFAOYSA-N 0.000 abstract 1
- 230000002295 serotoninergic effect Effects 0.000 abstract 1
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 48
- FVAUCKIRQBBSSJ-UHFFFAOYSA-M sodium iodide Chemical compound [Na+].[I-] FVAUCKIRQBBSSJ-UHFFFAOYSA-M 0.000 description 45
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 42
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 37
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 34
- 239000002904 solvent Substances 0.000 description 33
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 30
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 27
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 20
- 230000008018 melting Effects 0.000 description 20
- 238000002844 melting Methods 0.000 description 20
- 239000000203 mixture Substances 0.000 description 18
- XBPCUCUWBYBCDP-UHFFFAOYSA-N Dicyclohexylamine Chemical compound C1CCCCC1NC1CCCCC1 XBPCUCUWBYBCDP-UHFFFAOYSA-N 0.000 description 15
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 15
- 235000009518 sodium iodide Nutrition 0.000 description 15
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 14
- 239000003054 catalyst Substances 0.000 description 14
- 229910052739 hydrogen Inorganic materials 0.000 description 14
- 239000001257 hydrogen Substances 0.000 description 14
- 239000000047 product Substances 0.000 description 14
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 13
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 12
- LDCYZAJDBXYCGN-VIFPVBQESA-N 5-hydroxy-L-tryptophan Chemical compound C1=C(O)C=C2C(C[C@H](N)C(O)=O)=CNC2=C1 LDCYZAJDBXYCGN-VIFPVBQESA-N 0.000 description 10
- 239000010779 crude oil Substances 0.000 description 10
- 238000010898 silica gel chromatography Methods 0.000 description 10
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 9
- LDCYZAJDBXYCGN-UHFFFAOYSA-N 5-hydroxytryptophan Chemical compound C1=C(O)C=C2C(CC(N)C(O)=O)=CNC2=C1 LDCYZAJDBXYCGN-UHFFFAOYSA-N 0.000 description 8
- 239000013078 crystal Substances 0.000 description 8
- 238000005984 hydrogenation reaction Methods 0.000 description 8
- 239000000741 silica gel Substances 0.000 description 8
- 229910002027 silica gel Inorganic materials 0.000 description 8
- 239000003921 oil Substances 0.000 description 7
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 6
- 229940000681 5-hydroxytryptophan Drugs 0.000 description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 6
- 235000019253 formic acid Nutrition 0.000 description 6
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 5
- 239000012043 crude product Substances 0.000 description 5
- WBJINCZRORDGAQ-UHFFFAOYSA-N formic acid ethyl ester Natural products CCOC=O WBJINCZRORDGAQ-UHFFFAOYSA-N 0.000 description 5
- UKVIEHSSVKSQBA-UHFFFAOYSA-N methane;palladium Chemical compound C.[Pd] UKVIEHSSVKSQBA-UHFFFAOYSA-N 0.000 description 5
- 238000005406 washing Methods 0.000 description 5
- OMIHGPLIXGGMJB-UHFFFAOYSA-N 7-oxabicyclo[4.1.0]hepta-1,3,5-triene Chemical compound C1=CC=C2OC2=C1 OMIHGPLIXGGMJB-UHFFFAOYSA-N 0.000 description 4
- 238000001704 evaporation Methods 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- AZUYLZMQTIKGSC-UHFFFAOYSA-N 1-[6-[4-(5-chloro-6-methyl-1H-indazol-4-yl)-5-methyl-3-(1-methylindazol-5-yl)pyrazol-1-yl]-2-azaspiro[3.3]heptan-2-yl]prop-2-en-1-one Chemical compound ClC=1C(=C2C=NNC2=CC=1C)C=1C(=NN(C=1C)C1CC2(CN(C2)C(C=C)=O)C1)C=1C=C2C=NN(C2=CC=1)C AZUYLZMQTIKGSC-UHFFFAOYSA-N 0.000 description 3
- SXBHTALTCMWKHK-UHFFFAOYSA-N 2-(phenylmethoxycarbonylamino)-3-(5-phenylmethoxycarbonyloxy-1h-indol-3-yl)propanoic acid Chemical compound C=1C=CC=CC=1COC(=O)NC(C(=O)O)CC(C1=C2)=CNC1=CC=C2OC(=O)OCC1=CC=CC=C1 SXBHTALTCMWKHK-UHFFFAOYSA-N 0.000 description 3
- DUUGKQCEGZLZNO-UHFFFAOYSA-N 5-hydroxyindoleacetic acid Chemical compound C1=C(O)C=C2C(CC(=O)O)=CNC2=C1 DUUGKQCEGZLZNO-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 3
- 238000001727 in vivo Methods 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- GMEXDIGLKKXCMP-AWEZNQCLSA-N (2-butoxy-2-oxoethyl) (2S)-2-amino-3-(5-hydroxy-1H-indol-3-yl)propanoate Chemical compound CCCCOC(=O)COC(=O)[C@@H](N)CC1=CNC2=CC=C(O)C=C12 GMEXDIGLKKXCMP-AWEZNQCLSA-N 0.000 description 2
- KTBPPBZDSTVTRC-LBPRGKRZSA-N (2-ethoxy-2-oxoethyl) (2S)-2-amino-3-(5-hydroxy-1H-indol-3-yl)propanoate Chemical compound CCOC(=O)COC(=O)[C@@H](N)CC1=CNC2=CC=C(O)C=C12 KTBPPBZDSTVTRC-LBPRGKRZSA-N 0.000 description 2
- OJTZDYDFNWNWDA-NSHDSACASA-N (2-methoxy-2-oxoethyl) (2S)-2-amino-3-(5-hydroxy-1H-indol-3-yl)propanoate Chemical compound COC(=O)COC(=O)[C@@H](N)CC1=CNC2=CC=C(O)C=C12 OJTZDYDFNWNWDA-NSHDSACASA-N 0.000 description 2
- WNXQBGGRCHKMDT-SFHVURJKSA-N (2-octoxy-2-oxoethyl) (2S)-2-amino-3-(5-hydroxy-1H-indol-3-yl)propanoate Chemical compound CCCCCCCCOC(=O)COC(=O)[C@@H](N)CC1=CNC2=CC=C(O)C=C12 WNXQBGGRCHKMDT-SFHVURJKSA-N 0.000 description 2
- SIXGIXIGINHDBG-ZDUSSCGKSA-N (2-oxo-2-propoxyethyl) (2S)-2-amino-3-(5-hydroxy-1H-indol-3-yl)propanoate Chemical compound CCCOC(=O)COC(=O)[C@@H](N)CC1=CNC2=CC=C(O)C=C12 SIXGIXIGINHDBG-ZDUSSCGKSA-N 0.000 description 2
- QCQCHGYLTSGIGX-GHXANHINSA-N 4-[[(3ar,5ar,5br,7ar,9s,11ar,11br,13as)-5a,5b,8,8,11a-pentamethyl-3a-[(5-methylpyridine-3-carbonyl)amino]-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3h-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid Chemical compound N([C@@]12CC[C@@]3(C)[C@]4(C)CC[C@H]5C(C)(C)[C@@H](OC(=O)CC(C)(C)C(O)=O)CC[C@]5(C)[C@H]4CC[C@@H]3C1=C(C(C2)=O)C(C)C)C(=O)C1=CN=CC(C)=C1 QCQCHGYLTSGIGX-GHXANHINSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 208000012902 Nervous system disease Diseases 0.000 description 2
- 208000025966 Neurological disease Diseases 0.000 description 2
- ALVIEFYRZDDAHD-MHTVFEQDSA-N [2-(3,3-dimethylbutan-2-yloxy)-2-oxoethyl] (2S)-2-amino-3-(5-hydroxy-1H-indol-3-yl)propanoate Chemical compound OC=1C=C2C(=CNC2=CC=1)C[C@@H](C(=O)OCC(=O)OC(C)C(C)(C)C)N ALVIEFYRZDDAHD-MHTVFEQDSA-N 0.000 description 2
- HSDAJNMJOMSNEV-UHFFFAOYSA-N benzyl chloroformate Chemical compound ClC(=O)OCC1=CC=CC=C1 HSDAJNMJOMSNEV-UHFFFAOYSA-N 0.000 description 2
- 238000002306 biochemical method Methods 0.000 description 2
- YJRGMUWRPCPLNH-UHFFFAOYSA-N butyl 2-chloroacetate Chemical compound CCCCOC(=O)CCl YJRGMUWRPCPLNH-UHFFFAOYSA-N 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- FOCAUTSVDIKZOP-UHFFFAOYSA-N chloroacetic acid Chemical compound OC(=O)CCl FOCAUTSVDIKZOP-UHFFFAOYSA-N 0.000 description 2
- 229940106681 chloroacetic acid Drugs 0.000 description 2
- JPPYCWJDINILKY-UHFFFAOYSA-N dodecyl 2-chloroacetate Chemical compound CCCCCCCCCCCCOC(=O)CCl JPPYCWJDINILKY-UHFFFAOYSA-N 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000003480 eluent Substances 0.000 description 2
- LJWKFGGDMBPPAZ-UHFFFAOYSA-N ethoxyethane;toluene Chemical compound CCOCC.CC1=CC=CC=C1 LJWKFGGDMBPPAZ-UHFFFAOYSA-N 0.000 description 2
- VEUUMBGHMNQHGO-UHFFFAOYSA-N ethyl chloroacetate Chemical compound CCOC(=O)CCl VEUUMBGHMNQHGO-UHFFFAOYSA-N 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 125000003136 n-heptyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- 239000012299 nitrogen atmosphere Substances 0.000 description 2
- NNXMXUSTTDFBDE-UHFFFAOYSA-N octyl 2-chloroacetate Chemical compound CCCCCCCCOC(=O)CCl NNXMXUSTTDFBDE-UHFFFAOYSA-N 0.000 description 2
- 230000002093 peripheral effect Effects 0.000 description 2
- 229920001467 poly(styrenesulfonates) Polymers 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 239000013598 vector Substances 0.000 description 2
- NUTZPBPXIHDOJP-QFIPXVFZSA-N (2-dodecoxy-2-oxoethyl) (2S)-2-amino-3-(5-hydroxy-1H-indol-3-yl)propanoate Chemical compound CCCCCCCCCCCCOC(=O)COC(=O)[C@@H](N)CC1=CNC2=CC=C(O)C=C12 NUTZPBPXIHDOJP-QFIPXVFZSA-N 0.000 description 1
- UFTPVSIVOGOAFK-HKBQPEDESA-N (2-hexoxy-2-oxoethyl) (2S)-2-(phenylmethoxycarbonylamino)-3-(5-phenylmethoxycarbonyloxy-1H-indol-3-yl)propanoate Chemical compound C(C1=CC=CC=C1)OC(=O)OC=1C=C2C(=CNC2=CC=1)C[C@@H](C(=O)OCC(=O)OCCCCCC)NC(=O)OCC1=CC=CC=C1 UFTPVSIVOGOAFK-HKBQPEDESA-N 0.000 description 1
- WNJQDNPXSSRYLL-INIZCTEOSA-N (2-hexoxy-2-oxoethyl) (2S)-2-amino-3-(5-hydroxy-1H-indol-3-yl)propanoate Chemical compound CCCCCCOC(=O)COC(=O)[C@@H](N)CC1=CNC2=CC=C(O)C=C12 WNJQDNPXSSRYLL-INIZCTEOSA-N 0.000 description 1
- SCTIKXCQGSMUCA-XIFFEERXSA-N (2-octoxy-2-oxoethyl) (2S)-2-(phenylmethoxycarbonylamino)-3-(5-phenylmethoxycarbonyloxy-1H-indol-3-yl)propanoate Chemical compound C(C1=CC=CC=C1)OC(=O)OC=1C=C2C(=CNC2=CC=1)C[C@@H](C(=O)OCC(=O)OCCCCCCCC)NC(=O)OCC1=CC=CC=C1 SCTIKXCQGSMUCA-XIFFEERXSA-N 0.000 description 1
- IWBQVOVUTMNOJK-PMERELPUSA-N (2-oxo-2-pentoxyethyl) (2S)-2-(phenylmethoxycarbonylamino)-3-(5-phenylmethoxycarbonyloxy-1H-indol-3-yl)propanoate Chemical compound C(C1=CC=CC=C1)OC(=O)OC=1C=C2C(=CNC2=CC=1)C[C@@H](C(=O)OCC(=O)OCCCCC)NC(=O)OCC1=CC=CC=C1 IWBQVOVUTMNOJK-PMERELPUSA-N 0.000 description 1
- TYRGLVWXHJRKMT-MRVPVSSYSA-N (2r)-2-(phenylmethoxycarbonylamino)propanoic acid Chemical compound OC(=O)[C@@H](C)NC(=O)OCC1=CC=CC=C1 TYRGLVWXHJRKMT-MRVPVSSYSA-N 0.000 description 1
- SXBHTALTCMWKHK-DEOSSOPVSA-N (2s)-2-(phenylmethoxycarbonylamino)-3-(5-phenylmethoxycarbonyloxy-1h-indol-3-yl)propanoic acid Chemical compound C([C@@H](C(=O)O)NC(=O)OCC=1C=CC=CC=1)C(C1=C2)=CNC1=CC=C2OC(=O)OCC1=CC=CC=C1 SXBHTALTCMWKHK-DEOSSOPVSA-N 0.000 description 1
- FDWFFCURSPACFQ-UHFFFAOYSA-N 2-[(2-phenylacetyl)amino]propanoic acid Chemical compound OC(=O)C(C)NC(=O)CC1=CC=CC=C1 FDWFFCURSPACFQ-UHFFFAOYSA-N 0.000 description 1
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 1
- WFIYPADYPQQLNN-UHFFFAOYSA-N 2-[2-(4-bromopyrazol-1-yl)ethyl]isoindole-1,3-dione Chemical compound C1=C(Br)C=NN1CCN1C(=O)C2=CC=CC=C2C1=O WFIYPADYPQQLNN-UHFFFAOYSA-N 0.000 description 1
- LKFJVZRSORUMET-UHFFFAOYSA-N 2-[2-amino-3-(1h-indol-3-yl)propanoyl]oxyacetic acid Chemical class C1=CC=C2C(CC(N)C(=O)OCC(O)=O)=CNC2=C1 LKFJVZRSORUMET-UHFFFAOYSA-N 0.000 description 1
- QQWACHGKILUHGB-UHFFFAOYSA-N 2-isocyanatopropanoic acid Chemical compound OC(=O)C(C)N=C=O QQWACHGKILUHGB-UHFFFAOYSA-N 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 102000004031 Carboxy-Lyases Human genes 0.000 description 1
- 108090000489 Carboxy-Lyases Proteins 0.000 description 1
- VGCXGMAHQTYDJK-UHFFFAOYSA-N Chloroacetyl chloride Chemical compound ClCC(Cl)=O VGCXGMAHQTYDJK-UHFFFAOYSA-N 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- 229940123736 Decarboxylase inhibitor Drugs 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 241000700157 Rattus norvegicus Species 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 206010048669 Terminal state Diseases 0.000 description 1
- KNAVSOVDWNIXBT-JHXAUMMHSA-N [2-(1-adamantylmethoxy)-2-oxoethyl] (2S)-2-amino-3-(5-hydroxy-1H-indol-3-yl)propanoate Chemical compound N[C@@H](CC1=CNC2=CC=C(O)C=C12)C(=O)OCC(=O)OCC12CC3CC(CC(C3)C1)C2 KNAVSOVDWNIXBT-JHXAUMMHSA-N 0.000 description 1
- CBXMYUKXSLEKFT-POYPGSECSA-N [2-(3,3-dimethylbutan-2-yloxy)-2-oxoethyl] (2S)-2-(phenylmethoxycarbonylamino)-3-(5-phenylmethoxycarbonyloxy-1H-indol-3-yl)propanoate Chemical compound C(C1=CC=CC=C1)OC(=O)OC=1C=C2C(=CNC2=CC=1)C[C@@H](C(=O)OCC(=O)OC(C)C(C)(C)C)NC(=O)OCC1=CC=CC=C1 CBXMYUKXSLEKFT-POYPGSECSA-N 0.000 description 1
- 238000010306 acid treatment Methods 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- RTEXIPZMMDUXMR-UHFFFAOYSA-N benzene;ethyl acetate Chemical compound CCOC(C)=O.C1=CC=CC=C1 RTEXIPZMMDUXMR-UHFFFAOYSA-N 0.000 description 1
- 229960004217 benzyl alcohol Drugs 0.000 description 1
- MDHYEMXUFSJLGV-UHFFFAOYSA-N beta-phenethyl acetate Natural products CC(=O)OCCC1=CC=CC=C1 MDHYEMXUFSJLGV-UHFFFAOYSA-N 0.000 description 1
- 238000010256 biochemical assay Methods 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000008499 blood brain barrier function Effects 0.000 description 1
- 210000001218 blood-brain barrier Anatomy 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 230000007177 brain activity Effects 0.000 description 1
- 210000005013 brain tissue Anatomy 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 210000004720 cerebrum Anatomy 0.000 description 1
- 229920001429 chelating resin Polymers 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 125000001309 chloro group Chemical group Cl* 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 239000013058 crude material Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- 239000003954 decarboxylase inhibitor Substances 0.000 description 1
- 238000006114 decarboxylation reaction Methods 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000012156 elution solvent Substances 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000001506 fluorescence spectroscopy Methods 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- JUFPTDUONWPUBM-UHFFFAOYSA-N heptyl 2-chloroacetate Chemical compound CCCCCCCOC(=O)CCl JUFPTDUONWPUBM-UHFFFAOYSA-N 0.000 description 1
- QKGYJVXSKCDGOK-UHFFFAOYSA-N hexane;propan-2-ol Chemical compound CC(C)O.CCCCCC QKGYJVXSKCDGOK-UHFFFAOYSA-N 0.000 description 1
- OJGRZJILAIHWIY-UHFFFAOYSA-N hexyl 2-chloroacetate Chemical compound CCCCCCOC(=O)CCl OJGRZJILAIHWIY-UHFFFAOYSA-N 0.000 description 1
- 150000002475 indoles Chemical class 0.000 description 1
- 125000001041 indolyl group Chemical group 0.000 description 1
- 230000008991 intestinal motility Effects 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- QABLOFMHHSOFRJ-UHFFFAOYSA-N methyl 2-chloroacetate Chemical compound COC(=O)CCl QABLOFMHHSOFRJ-UHFFFAOYSA-N 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 125000001280 n-hexyl group Chemical group C(CCCCC)* 0.000 description 1
- 239000000712 neurohormone Substances 0.000 description 1
- 102000008434 neuropeptide hormone activity proteins Human genes 0.000 description 1
- 108040002669 neuropeptide hormone activity proteins Proteins 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000012044 organic layer Substances 0.000 description 1
- 229960002888 oxitriptan Drugs 0.000 description 1
- SAOZOMQLKLWJAN-UHFFFAOYSA-N pentyl 2-chloroacetate Chemical compound CCCCCOC(=O)CCl SAOZOMQLKLWJAN-UHFFFAOYSA-N 0.000 description 1
- ZWLUXSQADUDCSB-UHFFFAOYSA-N phthalaldehyde Chemical compound O=CC1=CC=CC=C1C=O ZWLUXSQADUDCSB-UHFFFAOYSA-N 0.000 description 1
- DFOXKPDFWGNLJU-UHFFFAOYSA-N pinacolyl alcohol Chemical compound CC(O)C(C)(C)C DFOXKPDFWGNLJU-UHFFFAOYSA-N 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 150000003141 primary amines Chemical class 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- QJZNRCWAXUGABH-UHFFFAOYSA-N propyl 2-chloroacetate Chemical compound CCCOC(=O)CCl QJZNRCWAXUGABH-UHFFFAOYSA-N 0.000 description 1
- 208000020016 psychiatric disease Diseases 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000006340 racemization Effects 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- KKCBUQHMOMHUOY-UHFFFAOYSA-N sodium oxide Chemical compound [O-2].[Na+].[Na+] KKCBUQHMOMHUOY-UHFFFAOYSA-N 0.000 description 1
- 229910001948 sodium oxide Inorganic materials 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 231100000820 toxicity test Toxicity 0.000 description 1
- ILWRPSCZWQJDMK-UHFFFAOYSA-N triethylazanium;chloride Chemical compound Cl.CCN(CC)CC ILWRPSCZWQJDMK-UHFFFAOYSA-N 0.000 description 1
- 238000010626 work up procedure Methods 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D209/20—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals substituted additionally by nitrogen atoms, e.g. tryptophane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Psychiatry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Indole Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
æ¬çºæã¯ãæ°èŠãªïŒâãïŒâïŒïŒâã€ã³ããª
ã«ïŒâïŒâã¢ããâããããªãã«ãªãã·ãé ¢é žèª
å°äœããã®è£œé æ¹æ³åã³ãããå«æããå»è¬ã«é¢
ããã ã»ãããã³ïŒåã¯ïŒâããããã·ããªãã¿ã
ã³ïŒãçäœå ã§ãã®çç©ç掻æ§ã«ããæŒãã圹å²
ã¯ç¥ãããŠãããè žã®éåæ§ã®èª¿ç¯ãå¹³æ»çãžã®
äœçšåã³è¡ç®¡åçž®äœçšã®ä»ã«ã粟ç¥éååã³ç²Ÿç¥
æ¬æ äœçšãã瀺ããè³ã®æŽ»åã«ãããã±ãã«ã«ã¡
ãã€ãšãŒã¿ãŒãšããŠéèŠãªäœçœ®ãå ããå®éã®ç¥
çµãã«ã¢ã³ãæ§æããã ã»ãããã³ç³»ã®æ¬ ä¹ïŒã»ãããã³ã¯äž»ã«é芪å
æ§çŽ°èããåæ³ãããç¹ã«æ¶å管ã®ã¬ãã«åã³è³
å ã®ã¬ãã«ã®æ¬ ä¹ïŒã¯ã粟ç¥å»åŠäžåã³ç¥çµåŠäž
ã®æ§ã ãªé節ãªé害ãåŒãèµ·ããåŸããåãã€ãŠ
調補ããã»ãããã³ãã»ãããã³äžè¶³ã®ç³»ãžäŸçµŠ
ããããšãäžå¯èœã§ããããããã®çŽåã®åé§äœ
å³ã¡äžèšåŒã§ç€ºãããïŒâããããã·ããªããã
ã¢ã³ïŒïŒâHTPïŒãçŸåšã«ãããŠããªãã»ãã
ãã³é¡äŒŒã®æãè¯ããã¯ã¿ãŒã§ããã ããããªããããã®æ§ãªãã¯ã¿ãŒã®æäžã¯ç¡èŠ
ã§ããªãæ¬ ç¹ãæãããå³ã¡ãïŒâããããã·ã
ãªãããã¢ã³ãã»ãããã³ãžå€æãããã«ã«ãã
ã·ã©ãŒãŒã¯æ«æ¢¢çµç¹ã«åºãååžããŠãããããè³
å ãžã®å°éããïŒâHTPã®çžåœéã®æ倱ãèµ·ã
ãã æ¬çºæã®ç®çã¯ãæ«æ¢¢çµç¹ã§ã®è±çé žã«å¯ŸããŠ
ããæµææ§ãããäžã€å€§è³ã§ïŒâHTPãšããŠã
ãè¯ãåçããããã«ãã€ãŠè³è¡æ¶²é¢éééæã®
åè¡ãå¢å ããïŒâHTPã®æ°èŠãªèªå°äœãæäŸ
ããããšã«ããã æ¬çºæã®æŽãªãç®çã¯ãæ«æ¶ã®ãã«ã«ããã·ã©
ãŒãŒé»å®³å€ãå°å ¥ããããšãªããæ«æ¶ã§ã®ïŒâ
HTPã®æ倱ãå€§å¹ ã«æžããããšã«ãããè³ã®ç
äœå ã»ãããã³ã¬ãã«ãå¢å ãããããšã«ããã æ¬çºæã®ååç©ã¯ãäžèšäžè¬åŒ ãåŒäžãã¯æ°ŽçŽ ååãçŽéè¥ããã¯åæç¶ã®
ççŽ æ°ïŒã12åã®ã¢ã«ãã«åºåã¯ã¡ãã¬ã³åºãçµ
åããããšã®ããççŽ æ°ïŒã16åã®åèç°è¥ãã
ã¯å€èç°çåæ°ŽçŽ åºã瀺ããã ã§è¡šããããïŒâãïŒâïŒïŒâã€ã³ããªã«ïŒâïŒ
âã¢ããâããããªãã«ãªãã·ãé ¢é žèªå°äœåã³
ãããã®è¬ççã«èš±å®¹ã§ããä»å å¡©ã§ããã æ¬çºæã«ããååç©ã¯ãããåã³åç©ã®æ²»çç¹
ã«ç²Ÿç¥å»åŠã®åéã«ãããŠè³å ã»ãããã³ã¬ãã«
å¢å è¬ãšããŠæ¥µããŠæçšãªå»è¬ã§ããã æ¬çºæã®ä»ã®äžé¢ã«ããã°ãäžèšåå¿åŒã«ç€ºã
ããåŠããæ¬çºæã®èªå°äœã®è£œé æ¹æ³ãæäŸãã
ãã å³ã¡ãåºçºã®é žããã®ããšããŒã«åã³ïŒå
ã¯ïŒã¢ãã³å®èœåºãR2OCOâåºïŒR2ã¯è³éŠæåº
ãæããããšã®ããèèªæåã¯è³éŠæä¿è·åºã瀺
ããïŒã§ä¿è·ããŠååç©ïŒïŒãšããâCH2â
COORïŒïŒïŒïŒïŒžã¯ããã²ã³åå奜ãŸããã¯å¡©çŽ
åååã¯èçŽ ååã瀺ããã¯åèšã«åããïŒãš
åå¿ãããšã¹ãã«åããŠååç©ïŒïŒãšããã次
ã«ããšããŒã«åã³ïŒåã¯ïŒã¢ãã³å®èœåºã®ä¿è·åº
ãè±ä¿è·ããŠç®çç©ïŒïŒãåŸããæ¬çºæã®è£œé
æ¹æ³ã®å¥œãŸããå®æœæ æ§ã«ããã°ãã¢ãã³åã³
ïŒåã¯ïŒããšããŒã«å®èœåºã¯ïŒžâCOOR2ïŒïŒå
ã³N3COOR2ïŒïŒïŒïŒžåã³R2ã¯åèšã«åããïŒã
ããªã矀ããéžã°ããè©Šè¬ã«ããä¿è·ãããã æ¬çºæã«ããä»ã®æå©ãªå®æœæ æ§ã§ã¯ãïŒâ
ïŒïŒâããããã·âïŒâã€ã³ããªã«ïŒé žèªå°äœã
ä¿è·è©Šè¬ïŒžâCOOR2ãšã®çž®åã¯ããã²ã³åæ°ŽçŽ
é žãå容ããå¡©åºã®ååšäžãžã¡ãã«ãã«ã ã¢ãã
çã®éãããã³æ§æº¶åªäžã§è¡ãªãããã æ¬çºæã«ããã°ãã¢ããåºåã³ïŒåã¯ïŒæ°Žé žåº
ã®è±ä¿è·ã¯é žåŠçã«ããè¡ãªããããæ¬çºæã«ã
ã補é æ¹æ³ã®ä»ã®ä¿®æ£ã§ã¯ãã¢ããåºåã³ïŒå
ã¯ïŒæ°Žé žåºã®è±ä¿è·ãæ¥è§Šéå ã«ããæããã
ãã å®éã®äžèšåå¿ã¯ãäžçŽã¢ãã³ã®çªçŽ ååã®çµ
åããäžæççŽ ã®äœçœ®ã§ã®ç«äœååŠã«åœ±é¿ããª
ããå åŠæŽ»æ§èªå°äœã®ã©ã»ãåã¯èµ·ããªãããšã
芳å¯ãããã ãŸãæ¬çºæã®ååç©ïŒïŒãè¬ççã«èš±å®¹ã§ã
ãä»å å¡©ãšããããšãã§ããã ãããŸã§ã«è¿°ã¹ãç¹åŸŽã®ä»ã«ãæ¬çºæãå å«ã
ãä»ã®ç¹åŸŽã¯ä»¥äžã®èšèŒããæããã«ãªãã§ãã
ãã æ¬çºæã®æ°èŠèªå°äœã®è£œé æ¹æ³ã®å®æœäŸãšè¬ç
è©Šéšã®ä»¥äžã®èšè¿°ã«ããæ¬çºæã¯ããè¯ãç解ã
ããã§ãããã ããããªããããããã®å®æœäŸã¯ãæ¬çºæã®ç
æç©åã³è£œé æ¹æ³ã®åãªãè¥å¹²ã®äŸã瀺ããã®ã«
éãããããã«ããæ¬çºæã®ç¯å²ãéå®ãããã
ã®ã§ã¯ãªãã å°ãååŠåŒïŒïŒã®çæç©ã®NMRïŒ1HïŒã¹ã
ã¯ãã«ã¯ããã¹ãŠæ¬¡ã®ç¹æ§ã·ã°ãã«ã瀺ãã ÎŽïŒppmïŒïŒ6.6ã7.6ïŒïœïŒ4HïŒè³éŠæ§ããã
ã³ïŒã4.7ïŒïœïŒ2HïŒ
ã«ïŒâïŒâã¢ããâããããªãã«ãªãã·ãé ¢é žèª
å°äœããã®è£œé æ¹æ³åã³ãããå«æããå»è¬ã«é¢
ããã ã»ãããã³ïŒåã¯ïŒâããããã·ããªãã¿ã
ã³ïŒãçäœå ã§ãã®çç©ç掻æ§ã«ããæŒãã圹å²
ã¯ç¥ãããŠãããè žã®éåæ§ã®èª¿ç¯ãå¹³æ»çãžã®
äœçšåã³è¡ç®¡åçž®äœçšã®ä»ã«ã粟ç¥éååã³ç²Ÿç¥
æ¬æ äœçšãã瀺ããè³ã®æŽ»åã«ãããã±ãã«ã«ã¡
ãã€ãšãŒã¿ãŒãšããŠéèŠãªäœçœ®ãå ããå®éã®ç¥
çµãã«ã¢ã³ãæ§æããã ã»ãããã³ç³»ã®æ¬ ä¹ïŒã»ãããã³ã¯äž»ã«é芪å
æ§çŽ°èããåæ³ãããç¹ã«æ¶å管ã®ã¬ãã«åã³è³
å ã®ã¬ãã«ã®æ¬ ä¹ïŒã¯ã粟ç¥å»åŠäžåã³ç¥çµåŠäž
ã®æ§ã ãªé節ãªé害ãåŒãèµ·ããåŸããåãã€ãŠ
調補ããã»ãããã³ãã»ãããã³äžè¶³ã®ç³»ãžäŸçµŠ
ããããšãäžå¯èœã§ããããããã®çŽåã®åé§äœ
å³ã¡äžèšåŒã§ç€ºãããïŒâããããã·ããªããã
ã¢ã³ïŒïŒâHTPïŒãçŸåšã«ãããŠããªãã»ãã
ãã³é¡äŒŒã®æãè¯ããã¯ã¿ãŒã§ããã ããããªããããã®æ§ãªãã¯ã¿ãŒã®æäžã¯ç¡èŠ
ã§ããªãæ¬ ç¹ãæãããå³ã¡ãïŒâããããã·ã
ãªãããã¢ã³ãã»ãããã³ãžå€æãããã«ã«ãã
ã·ã©ãŒãŒã¯æ«æ¢¢çµç¹ã«åºãååžããŠãããããè³
å ãžã®å°éããïŒâHTPã®çžåœéã®æ倱ãèµ·ã
ãã æ¬çºæã®ç®çã¯ãæ«æ¢¢çµç¹ã§ã®è±çé žã«å¯ŸããŠ
ããæµææ§ãããäžã€å€§è³ã§ïŒâHTPãšããŠã
ãè¯ãåçããããã«ãã€ãŠè³è¡æ¶²é¢éééæã®
åè¡ãå¢å ããïŒâHTPã®æ°èŠãªèªå°äœãæäŸ
ããããšã«ããã æ¬çºæã®æŽãªãç®çã¯ãæ«æ¶ã®ãã«ã«ããã·ã©
ãŒãŒé»å®³å€ãå°å ¥ããããšãªããæ«æ¶ã§ã®ïŒâ
HTPã®æ倱ãå€§å¹ ã«æžããããšã«ãããè³ã®ç
äœå ã»ãããã³ã¬ãã«ãå¢å ãããããšã«ããã æ¬çºæã®ååç©ã¯ãäžèšäžè¬åŒ ãåŒäžãã¯æ°ŽçŽ ååãçŽéè¥ããã¯åæç¶ã®
ççŽ æ°ïŒã12åã®ã¢ã«ãã«åºåã¯ã¡ãã¬ã³åºãçµ
åããããšã®ããççŽ æ°ïŒã16åã®åèç°è¥ãã
ã¯å€èç°çåæ°ŽçŽ åºã瀺ããã ã§è¡šããããïŒâãïŒâïŒïŒâã€ã³ããªã«ïŒâïŒ
âã¢ããâããããªãã«ãªãã·ãé ¢é žèªå°äœåã³
ãããã®è¬ççã«èš±å®¹ã§ããä»å å¡©ã§ããã æ¬çºæã«ããååç©ã¯ãããåã³åç©ã®æ²»çç¹
ã«ç²Ÿç¥å»åŠã®åéã«ãããŠè³å ã»ãããã³ã¬ãã«
å¢å è¬ãšããŠæ¥µããŠæçšãªå»è¬ã§ããã æ¬çºæã®ä»ã®äžé¢ã«ããã°ãäžèšåå¿åŒã«ç€ºã
ããåŠããæ¬çºæã®èªå°äœã®è£œé æ¹æ³ãæäŸãã
ãã å³ã¡ãåºçºã®é žããã®ããšããŒã«åã³ïŒå
ã¯ïŒã¢ãã³å®èœåºãR2OCOâåºïŒR2ã¯è³éŠæåº
ãæããããšã®ããèèªæåã¯è³éŠæä¿è·åºã瀺
ããïŒã§ä¿è·ããŠååç©ïŒïŒãšããâCH2â
COORïŒïŒïŒïŒïŒžã¯ããã²ã³åå奜ãŸããã¯å¡©çŽ
åååã¯èçŽ ååã瀺ããã¯åèšã«åããïŒãš
åå¿ãããšã¹ãã«åããŠååç©ïŒïŒãšããã次
ã«ããšããŒã«åã³ïŒåã¯ïŒã¢ãã³å®èœåºã®ä¿è·åº
ãè±ä¿è·ããŠç®çç©ïŒïŒãåŸããæ¬çºæã®è£œé
æ¹æ³ã®å¥œãŸããå®æœæ æ§ã«ããã°ãã¢ãã³åã³
ïŒåã¯ïŒããšããŒã«å®èœåºã¯ïŒžâCOOR2ïŒïŒå
ã³N3COOR2ïŒïŒïŒïŒžåã³R2ã¯åèšã«åããïŒã
ããªã矀ããéžã°ããè©Šè¬ã«ããä¿è·ãããã æ¬çºæã«ããä»ã®æå©ãªå®æœæ æ§ã§ã¯ãïŒâ
ïŒïŒâããããã·âïŒâã€ã³ããªã«ïŒé žèªå°äœã
ä¿è·è©Šè¬ïŒžâCOOR2ãšã®çž®åã¯ããã²ã³åæ°ŽçŽ
é žãå容ããå¡©åºã®ååšäžãžã¡ãã«ãã«ã ã¢ãã
çã®éãããã³æ§æº¶åªäžã§è¡ãªãããã æ¬çºæã«ããã°ãã¢ããåºåã³ïŒåã¯ïŒæ°Žé žåº
ã®è±ä¿è·ã¯é žåŠçã«ããè¡ãªããããæ¬çºæã«ã
ã補é æ¹æ³ã®ä»ã®ä¿®æ£ã§ã¯ãã¢ããåºåã³ïŒå
ã¯ïŒæ°Žé žåºã®è±ä¿è·ãæ¥è§Šéå ã«ããæããã
ãã å®éã®äžèšåå¿ã¯ãäžçŽã¢ãã³ã®çªçŽ ååã®çµ
åããäžæççŽ ã®äœçœ®ã§ã®ç«äœååŠã«åœ±é¿ããª
ããå åŠæŽ»æ§èªå°äœã®ã©ã»ãåã¯èµ·ããªãããšã
芳å¯ãããã ãŸãæ¬çºæã®ååç©ïŒïŒãè¬ççã«èš±å®¹ã§ã
ãä»å å¡©ãšããããšãã§ããã ãããŸã§ã«è¿°ã¹ãç¹åŸŽã®ä»ã«ãæ¬çºæãå å«ã
ãä»ã®ç¹åŸŽã¯ä»¥äžã®èšèŒããæããã«ãªãã§ãã
ãã æ¬çºæã®æ°èŠèªå°äœã®è£œé æ¹æ³ã®å®æœäŸãšè¬ç
è©Šéšã®ä»¥äžã®èšè¿°ã«ããæ¬çºæã¯ããè¯ãç解ã
ããã§ãããã ããããªããããããã®å®æœäŸã¯ãæ¬çºæã®ç
æç©åã³è£œé æ¹æ³ã®åãªãè¥å¹²ã®äŸã瀺ããã®ã«
éãããããã«ããæ¬çºæã®ç¯å²ãéå®ãããã
ã®ã§ã¯ãªãã å°ãååŠåŒïŒïŒã®çæç©ã®NMRïŒ1HïŒã¹ã
ã¯ãã«ã¯ããã¹ãŠæ¬¡ã®ç¹æ§ã·ã°ãã«ã瀺ãã ÎŽïŒppmïŒïŒ6.6ã7.6ïŒïœïŒ4HïŒè³éŠæ§ããã
ã³ïŒã4.7ïŒïœïŒ2HïŒ
çªçŽ é°å²æ°äžåžžæž©ã§ãïŒïŒ¬âïŒâããããã·
âããªãããã¢ã³44ïœïŒ0.2ã¢ã«ïŒãæ°Žé žåãã
ãªãŠã ïŒïœãå«æããæ°ŽïŒã«æº¶è§£ããã¯ããè»
é žãã³ãžã« 28.5mlãã¢ã»ãã³150mlã«æº¶è§£ãã
ãã®ã«ãåžæ°Žé žåãããªãŠã ãå ããŠPH9.5ã«ä¿
ã¡ã€ã€ïŒæéãããŠå ããã宀枩ã§æ°æéæ¹æ
åŸãã¢ã»ãã³ãæžå§äžçå»ããåŸãããã¢ã«ã«ãª
æ§æ°Žæº¶æ¶²ãéå°ã®å·åžå¡©é žã«æµã蟌ãã ãæ²æ®¿ã
å¥ãããã°ããæŽæµãã空æ°ãå ã«åœãŠãªãã
ãã«ããŠä¹Ÿç¥ãããç²è£œç©ïŒïŒ²dtïŒ100ïŒ ïŒãã
å ãé®èœããŠãã·ãªã«ã²ã«ã¯ãããã°ã©ãã€ãŒã«
ãããã³ãŒã³âã¡ã¿ããŒã«æ··åç©ã§æº¶åºããŠç²Ÿè£œ
ãããèç¹80âã®çŽç²ãªçæç©26ïœïŒïŒ²dtïŒ37
ïŒ ïŒãåŸãã ïœ ãšã㫠ïŒïŒ¬âïŒâãïŒâïŒïŒâãããã
ã·âïŒâã€ã³ããªã«ïŒïŒâãã³ãžã«ãªãã·ã«ã«
ããã«ã¢ããâããããªãã«ãªãã·ãã¢ã»ããŒ
ã ïŒïŒ¬âïŒâïŒïŒâããããã·âïŒâã€ã³ããª
ã«ïŒâïŒâãã³ãžã«ãªãã·ã«ã«ããã«ã¢ããâã
ãããªã³é žïŒå®æœäŸ1dïŒã§åŸããã®ïŒ17.7ïœ
ïŒ0.05ã¢ã«ïŒãæ²åãããªãŠã 0.5ïœãã¯ããé ¢é ž
ãšãã«6.1ïœïŒ0.05ã¢ã«ïŒããžã·ã¯ãããã·ã«ã¢ã
ã³10mlåã³ãžã¡ãã«ãã«ã ã¢ãã100mlã®æ··åç©
ãåžžæž©ã§20æéæ¹æãã次ãã§å®æœäŸ1bïŒãšå
æ§ã«ããŠåŠçãããæ®æž£ã®ç²ãªã€ã«ãã·ãªã«ã²ã«
ã¯ãããã°ã©ãã€ãŒã«ããããã³ãŒã³âé ¢é žãšã
ã«æ··åç©ã§æº¶åºãããåŸãããç²çš ãªãªã€ã«16.2
ïœã¯ã·ãªã«ã²ã«TLCïŒæº¶åªç³»ããã«ãšã³ïŒè»é ž
ãšãã«ïŒè»é žïŒ80ïŒ40ïŒïŒïŒã«ãããŠRfïŒ0.55ã«
åäžã®ã¹ãããã®ã¿ã瀺ããã NMRïŒ1HïŒã¹ãã¯ãã«ã¯æ¬¡ã®ç¹æ§ã·ã°ãã«ã
瀺ããã ÎŽïŒinDMSOâïœãïŒppmïŒïŒ7.3ïŒïœïŒ5HïŒ
ãã³ãžã«åºã®è³éŠæ§ãããã³ïŒã6.8ã7.2
ïŒïœïŒ4HïŒã€ã³ããŒã«åºã®è³éŠæ§ããã
ã³ïŒã5.2ïŒïœïŒ2HïŒãã³ãžã«åºã®ã¡ãã¬ã³
ãããã³ïŒã4.7ïŒïœïŒ2HïŒ
âããªãããã¢ã³44ïœïŒ0.2ã¢ã«ïŒãæ°Žé žåãã
ãªãŠã ïŒïœãå«æããæ°ŽïŒã«æº¶è§£ããã¯ããè»
é žãã³ãžã« 28.5mlãã¢ã»ãã³150mlã«æº¶è§£ãã
ãã®ã«ãåžæ°Žé žåãããªãŠã ãå ããŠPH9.5ã«ä¿
ã¡ã€ã€ïŒæéãããŠå ããã宀枩ã§æ°æéæ¹æ
åŸãã¢ã»ãã³ãæžå§äžçå»ããåŸãããã¢ã«ã«ãª
æ§æ°Žæº¶æ¶²ãéå°ã®å·åžå¡©é žã«æµã蟌ãã ãæ²æ®¿ã
å¥ãããã°ããæŽæµãã空æ°ãå ã«åœãŠãªãã
ãã«ããŠä¹Ÿç¥ãããç²è£œç©ïŒïŒ²dtïŒ100ïŒ ïŒãã
å ãé®èœããŠãã·ãªã«ã²ã«ã¯ãããã°ã©ãã€ãŒã«
ãããã³ãŒã³âã¡ã¿ããŒã«æ··åç©ã§æº¶åºããŠç²Ÿè£œ
ãããèç¹80âã®çŽç²ãªçæç©26ïœïŒïŒ²dtïŒ37
ïŒ ïŒãåŸãã ïœ ãšã㫠ïŒïŒ¬âïŒâãïŒâïŒïŒâãããã
ã·âïŒâã€ã³ããªã«ïŒïŒâãã³ãžã«ãªãã·ã«ã«
ããã«ã¢ããâããããªãã«ãªãã·ãã¢ã»ããŒ
ã ïŒïŒ¬âïŒâïŒïŒâããããã·âïŒâã€ã³ããª
ã«ïŒâïŒâãã³ãžã«ãªãã·ã«ã«ããã«ã¢ããâã
ãããªã³é žïŒå®æœäŸ1dïŒã§åŸããã®ïŒ17.7ïœ
ïŒ0.05ã¢ã«ïŒãæ²åãããªãŠã 0.5ïœãã¯ããé ¢é ž
ãšãã«6.1ïœïŒ0.05ã¢ã«ïŒããžã·ã¯ãããã·ã«ã¢ã
ã³10mlåã³ãžã¡ãã«ãã«ã ã¢ãã100mlã®æ··åç©
ãåžžæž©ã§20æéæ¹æãã次ãã§å®æœäŸ1bïŒãšå
æ§ã«ããŠåŠçãããæ®æž£ã®ç²ãªã€ã«ãã·ãªã«ã²ã«
ã¯ãããã°ã©ãã€ãŒã«ããããã³ãŒã³âé ¢é žãšã
ã«æ··åç©ã§æº¶åºãããåŸãããç²çš ãªãªã€ã«16.2
ïœã¯ã·ãªã«ã²ã«TLCïŒæº¶åªç³»ããã«ãšã³ïŒè»é ž
ãšãã«ïŒè»é žïŒ80ïŒ40ïŒïŒïŒã«ãããŠRfïŒ0.55ã«
åäžã®ã¹ãããã®ã¿ã瀺ããã NMRïŒ1HïŒã¹ãã¯ãã«ã¯æ¬¡ã®ç¹æ§ã·ã°ãã«ã
瀺ããã ÎŽïŒinDMSOâïœãïŒppmïŒïŒ7.3ïŒïœïŒ5HïŒ
ãã³ãžã«åºã®è³éŠæ§ãããã³ïŒã6.8ã7.2
ïŒïœïŒ4HïŒã€ã³ããŒã«åºã®è³éŠæ§ããã
ã³ïŒã5.2ïŒïœïŒ2HïŒãã³ãžã«åºã®ã¡ãã¬ã³
ãããã³ïŒã4.7ïŒïœïŒ2HïŒ
ãåŒãïŒã4.2ïŒïœïŒ2HïŒâCH2â
CH3ïŒã4.2ïŒïœïŒ1HïŒ
ãåŒãïŒã3.3ïŒïœïŒ2HïŒ
ãåŒãïŒã1.2ïŒïœïŒ3HïŒâCH2â
CH3ïŒ
ïœ ãšã㫠ïŒïŒ¬âïŒâãïŒâïŒïŒâãããã
ã·âïŒâã€ã³ããªã«ïŒâïŒâã¢ããâããããª
ãã«ãªãã·ãã¢ã»ããŒã äžèšã§åŸãèªå°äœ8.8ïœïŒ0.020ã¢ã«ïŒãã€ãœã
ããããŒã«150mläžïŒïŒ ãã©ãžãŠã âççŽ ïŒïœã®
ååšäžã§ãæ°ŽçŽ æ·»å ãããå®æœäŸ1cïŒã«åŸã€ãŠåŠ
çããŠãèç¹93ã94âã®ååç©ãåŸããããã¯å®
æœäŸ1aïŒïŒ1bïŒïŒ1cïŒã«ããã®é åºã§ãåŸã€ãŠåŸ
ããããã®ãšåäžã§ãã€ãã å®æœäŸ ïŒ ãã㫠ïŒïŒ¬âïŒâãïŒâïŒïŒâããããã·
âïŒâã€ã³ããªã«ïŒâïŒâã¢ããâããããªã
ã«ãªãã·ãã¢ã»ããŒã ãäžè¬åŒïŒïŒãïŒC4H9ã ïœ ãã㫠ïŒïŒ¬âïŒâãïŒâïŒïŒâãã³ãžã«
ãªãã·ã«ã«ããã«ãªãã·âïŒâã€ã³ããªã«ïŒâ
ïŒâãã³ãžã«ãªãã·ã«ã«ããã«ã¢ããâããã
ãªãã«ãªãã·ãã¢ã»ããŒã åžžæž©äžãäžèšè©Šè¬ãæ··åããã ïŒïŒ¬âïŒâïŒïŒâãã³ãžã«ãªãã·ã«ã«ããã«
ãªãã·âïŒâã€ã³ããªã«ïŒâïŒâãã³ãžã«ãªãã·
ã«ã«ããã«ã¢ããâããããªã³é žïŒå®æœäŸ1aïŒã§
åŸããã®ïŒ100ïœïŒ0.2ã¢ã«ïŒããžã·ã¯ãããã·ã«
ã¢ãã³40mlïŒ0.2ã¢ã«ïŒãã¯ããé ¢é žããã« 28.3
mlïŒ0.2ã¢ã«ïŒããžã¡ãã«ãã«ã ã¢ãã600mlåã³
æ²åãããªãŠã ïŒïœã 次ãã§æ··åç©ãå®æœäŸ1bïŒãšåæ§ã«ããŠåŠç
ããã ç²è£œç©125ïœãåŸããããã¯ã€ãœãããããŒã«
次ãã§ãšã¿ããŒã«ã§çµæ¶åã粟補ã§ãããããã
ãŠç®çç©ãåŸããèç¹90âïŒã³ãã©ãŒïŒã ïœ ãã㫠ïŒïŒ¬âïŒâãïŒâïŒïŒâãããã
ã·âïŒâã€ã³ããªã«ïŒâïŒâã¢ããâããããª
ãã«ãªãã·ãã¢ã»ããŒã äžèšã§åŸãååç©25ïœããã€ãœãããããŒã«
500mläžã§ïŒïŒ ãã©ãžãŠã âççŽ 2.5ïœã®ååšäžã«
æ°ŽçŽ æ·»å ãããçè«éã®æ°ŽçŽ ãåžåãããæã觊
åªãå»ãã溶åªãçå»ããé ¢é žãšãã«ã«æº¶è§£ã
ããæ°ŽæŽåŸæº¶åªãçå»ããçæç©ãã·ãªã«ã²ã«ã¯
ãããã°ã©ãã€ãŒã«ãã粟補ããç®çç©ãåŸãã
åç50ïŒ ãèç¹90âã å®æœäŸ ïŒ ãªã¯ã㫠ïŒïŒ¬âïŒâãïŒâïŒïŒâãããã
ã·âïŒâã€ã³ããªã«ïŒâïŒâã¢ããâããããª
ãã«ãªãã·ãã¢ã»ããŒã ãäžè¬åŒïŒïŒãïŒC8H17ã ïœ ãªã¯ã㫠ïŒïŒ¬âïŒâãïŒâïŒïŒâãã³ãž
ã«ãªãã·ã«ã«ããã«ãªãã·âïŒâã€ã³ããªã«ïŒ
âïŒâãã³ãžã«ãªãã·ã«ã«ããã«ã¢ããâãã
ããªãã«ãªãã·ãã¢ã»ããŒã ïŒïŒ¬âïŒâïŒïŒâãã³ãžã«ãªãã·ã«ã«ããã«
ãªãã·âïŒâã€ã³ããªã«ïŒâïŒâãã³ãžã«ãªãã·
ã«ã«ããã«ã¢ããâããããªã³é ž100ïœïŒ0.2ã¢
ã«ïŒããžã¡ãã«ãã«ã ã¢ãã600mlããžã·ã¯ããã
ã·ã«ã¢ãã³40mlïŒ0.2ã¢ã«ïŒãæ²åãããªãŠã ïŒïœ
åã³ã¯ããé ¢é žãªã¯ãã«41.3ïœïŒ0.2ã¢ã«ïŒã®æ··
åç©ã20æéæ¹æãã次ãã§å®æœäŸ1bïŒãšåæ§
ã«ããŠåŠçãããçµè£œç©ããã·ã¬ã³ããåçµæ¶ã
ãŠãçŸããçœè²çµæ¶36ïœãåŸããèç¹96âã ïœ ãªã¯ã㫠ïŒïŒ¬âïŒâãïŒâïŒïŒâããã
ãã·âïŒâã€ã³ããªã«ïŒâïŒâã¢ããâããã
ãªãã«ãªãã·ãã¢ã»ããŒã 倧æ°å§äžã«äžèšã§åŸãååç©50ïœïŒ0.075ã¢
ã«ïŒããã€ãœãããããŒã«500mläžïŒïŒ ãã©ãžãŠ
ã âççŽ ïŒïœã®ååšäžã«æ°ŽçŽ æ·»å ãããçè«éã®
æ°ŽçŽ ãæ¶è²»ãããæã觊åªãå»ããèžçºä¹Ÿåº
åŸãé ¢é žãšãã«ã«æº¶è§£ãããææ©å±€ãæ°ŽæŽããæ
æã§åŠçã次ãã§æº¶åªãçå»ãããç²ãªã€ã«ãåŸ
ãããã·ã¯ããããµã³ã§çµæ¶åãããèç¹91âã å®æœäŸ ïŒ ããã·ã« ïŒïŒ¬âïŒâãïŒâïŒïŒâãããã
ã·âïŒâã€ã³ããªã«ïŒâïŒâã¢ããâããããª
ãã«ãªãã·ãã¢ã»ããŒã ãäžè¬åŒïŒïŒãïŒC12H25ã ïœ ããã·ã« ïŒïŒ¬âïŒâãïŒâïŒïŒâãã³ãž
ã«ãªãã·ã«ã«ããã«ãªãã·âïŒâã€ã³ããªã«ïŒ
âïŒâãã³ãžã«ãªãã·ã«ã«ããã«ã¢ããâãã
ããªãã«ãªãã·ãã¢ã»ããŒã ïŒïŒ¬âïŒâïŒïŒâãã³ãžã«ãªãã·ã«ã«ããã«
ãªãã·âïŒâã€ã³ããªã«ïŒâïŒâãã³ãžã«ãªãã·
ã«ã«ããã«ã¢ããâããããªã³é žïŒå®æœäŸ1aïŒã§
åŸããã®ïŒ25ïœïŒ0.05ã¢ã«ïŒããžã¡ãã«ãã«ã ã¢
ãã200mlããžã·ã¯ãããã·ã«ã¢ãã³10mlãæ²å
ãããªãŠã 500mgåã¯ããé ¢é žããã·ã«13.2ïœã
æ··åããæ··åç©ãå®æœäŸ1bïŒãšåæ§ã«ããŠåŠç
ãããçæç©ãã€ãœãããããŒã«âãããµã³æ··æ¶²
ããåçµæ¶ããã ïœ ããã·ã« ïŒïŒ¬âïŒâãïŒâïŒïŒâããã
ãã·âïŒâã€ã³ããªã«ïŒâïŒâã¢ããâããã
ãªãã«ãªãã·ãã¢ã»ããŒã äžèšã§åŸãååç©25ïœããã€ãœãããããŒã«
500mläžã§ïŒïŒ ãã©ãžãŠã âççŽ 2.5ïœã®ååšäžã«
æ°ŽçŽ æ·»å ãããè«çéã®æ°ŽçŽ ãåžåãããæã觊
åªãå»ããèžçºä¹Ÿåºããé ¢é žãšãã«ã«æº¶è§£ãã
æ°ŽæŽãããå¡©é žã§åŠçããããšã«ãããçŽæ¥å¡©é ž
å¡©ãåé¢ã§ãããèç¹122ã124âã å®æœäŸ ïŒ ã¡ã㫠âïŒâãïŒâïŒïŒâããããã·âïŒ
âã€ã³ããªã«ïŒâïŒâã¢ããâããããªãã«ãª
ãã·ãã¢ã»ããŒã ãäžè¬åŒïŒïŒãïŒCH3ã ïœ ïŒ¬âïŒâïŒïŒâãã³ãžã«ãªãã·ã«ã«ããã«ãª
ãã·âïŒâã€ã³ããªã«ïŒâïŒâãã³ãžã«ãªãã·
ã«ã«ããã«ã¢ããâããããªã³é ž çªçŽ é°å²æ°äžãâïŒâããããã·ããªããã
ã¢ã³220ïœãæ°ŽïŒã«æº¶è§£ããã©ã»ãååç©ã«ã€
ãå®æœäŸ1aïŒã§çšããæ¹æ³ã«åŸããã¯ããè»é žã
ã³ãžã«ã§åŠçãããäžèšã«ããç²ãªã€ã«ïŒ93ïŒ ïŒ
ãåŸããç²è£œç©ãâååç©ã«ã€ãçšããæ¹æ³
ã«åŸã粟補ãããçœè²çµæ¶ãåç40ïŒ ã§åŸããè
ç¹145ã146âããαãïŒïŒ ïŒâ7.1ãïŒïŒ£ïŒ0.5ïŒ ãç¡
æ°Žãšã¿ããŒã«ïŒãâ9.9ãïŒïŒ£ïŒïŒïŒ ãã¢ã»ãã³ïŒã ïœ ã¡ã㫠âïŒâãïŒâïŒïŒâãã³ãžã«ãªã
ã·ã«ã«ããã«ãªãã·âïŒâã€ã³ããªã«ïŒâïŒâ
ãã³ãžã«ãªãã·ã«ã«ããã«ã¢ããâããããªã
ã«ãªãã·ãã¢ã»ããŒã âïŒâïŒïŒâãã³ãžã«ãªãã·ã«ã«ããã«ãªã
ã·âïŒâã€ã³ããªã«ïŒâïŒâãã³ãžã«ãªãã·ã«ã«
ããã«ã¢ããâããããªã³é žïŒå®æœäŸ5aïŒã§åŸã
ãã®ïŒ50ïœïŒ0.1ã¢ã«ïŒããžã¡ãã«ãã«ã ã¢ãã
300mlããžã·ã¯ãããã·ã«ã¢ãã³20mlãæ²åãã
ãªãŠã ïŒïœåã³ã¯ããé ¢é žã¡ãã«11ïœïŒ0.1ã¢
ã«ïŒã®æ··åç©ã20æéæ¹æããå®æœäŸ1bïŒãšå
æ§ã«ããŠåŠçããã溶åªãçå»åŸããã³ãŒã³âãš
ãŒãã«æ··æ¶²ãå±é溶åªãšããŠã·ãªã«ã²ã«ã¯ããã
ã°ã©ãã€ãŒã«ãã粟補ãããçŽç²ãªãªã€ã«ã¯ãã
ã«ãšã³80ãè»é žãšãã«40åã³è»é žïŒã®ç³»ã«ããã
ã·ãªã«æ¿äžC.C.Mã«ãããŠRfïŒ0.6ã®åäžã¹ãã
ãã®ã¿ãæããŠãããããããã®ãŸãŸäžèšå·¥çšã«
çšããã ïœ ã¡ã㫠âïŒâãïŒâïŒïŒâããããã·â
ïŒâã€ã³ããªã«ïŒâïŒâã¢ããâããããªãã«
ãªãã·ãã¢ã»ããŒã äžèšååç©28ïœïŒ0.05ã¢ã«ïŒãã€ãœãããããŒ
ã«æº¶æ¶²ãšããïŒïŒ ãã©ãžãŠã âççŽ 2.5ïœã®ååš
äžã«æ°ŽçŽ æ·»å ãããçè«éã®æ°ŽçŽ ãåºå®ããã
æã觊åªãå»ãã溶åªãçå»ããé ¢é žãšãã«ã§
æœåºããæ°ŽæŽãã次ãã§æº¶åªçå»ã®åŸãã³ãŒã³ã§
åçµæ¶ãããçœè²çµæ¶ïŒåç50ïŒ ïŒãåŸããèç¹
125âïŒã³ãã©ãŒïŒããαãïŒïŒ ïŒâ59ãïŒïŒ£ïŒïŒïŒ
ã
ã¢ã»ãã³ïŒã å®æœäŸ ïŒ ãšã㫠âïŒâãïŒâïŒïŒâããããã·âïŒ
âã€ã³ããªã«ïŒâïŒâã¢ããããããªãã«ãªã
ã·ãã¢ã»ããŒã ãäžè¬åŒïŒïŒãïŒC2H5ã ïœ ãšã㫠âïŒâãïŒâïŒïŒâãã³ãžã«ãªã
ã·ã«ã«ããã«ãªãã·âïŒâã€ã³ããªã«ïŒâïŒâ
ãã³ãžã«ãªãã·ã«ã«ããã«ã¢ããâããããªã
ã«ãªãã·ãã¢ã»ããŒã å®æœäŸ5aïŒã§åŸãâïŒâïŒïŒâãã³ãžã«ãªã
ã·ã«ã«ããã«ãªãã·âïŒâã€ã³ããªã«ïŒâïŒâã
ã³ãžã«ãªãã·ã«ã«ããã«ã¢ããâããããªã³é ž50
ïœïŒ0.1ã¢ã«ïŒããžã¡ãã«ãã«ã ã¢ãã300mlããž
ã·ã¯ãããã·ã«ã¢ãã³20mlãæ²åãããªãŠã ïŒïœ
åã³ã¯ããé ¢é žãšãã«10.5mlã®æ··åç©ãã20æé
æ¹æããå®æœäŸ1bïŒãšåæ§ã«åŠçããã溶åªã
å®å šã«çå»ããŠãè€è²ãªã€ã«51ïœãåŸããããã¯
ãã«ãšã³80ãè»é žãšãã«40åã³è»é žïŒã®ç³»ã«ãã
ããâãŒã«ã²ã«TICã«ãããŠRfïŒ0.6ã®åäžã¹ã
ããã®ã¿ãäžãããçæç©ã®IRåæçµæã§ã¯ã
3400cm-1åã³1740cm-1ã«ç¹åŸŽçãªãã³ããèªãã
ããã ãαãïŒïŒ ïŒâ22.55ãïŒïŒ£ïŒïŒïŒ ããšã¿ããŒã«ïŒ ïœ ãšã㫠âïŒâãïŒâïŒïŒâããããã·â
ïŒâã€ã³ããªã«ïŒâïŒâã¢ããâããããªãã«
ãªãã·ãã¢ã»ããŒã 倧æ°å§äžã«äžèšã§åŸãååç©49ïœïŒ0.0854ã¢
ã«ïŒãã€ãœãããããŒã«ã®æº¶æ¶²ãšããïŒïŒ ãã©ãž
ãŠã âççŽ 2.5ïœã®ååšäžã«æ°ŽçŽ æ·»å ãããçè«
éã®æ°ŽçŽ ãåºå®ãããæã觊åªãå»ãã溶åªã
çå»ããé ¢é žãšãã«äžã«æº¶è§£ããæ°ŽæŽåŸææã§åŠ
çã溶åªãçå»ãããæ®æž£ãå床ã€ãœãããããŒ
ã«äžã®æº¶è§£ããå¡©é žå¡©ãšãïŒããã¯å·æã§çµæ¶å
ããïŒãéããæ°ŽæŽãã也ç¥ãããå¡©é žå¡©20.8
ïœïŒåç71ïŒ ïŒãåŸããèç¹257ã260âã è©²å¡©é žå¡©ã¯åžéã¢ã³ã¢ãã¢æ°Žã§åŠçããå¡©åºãš
ãªãããããéãæ°ŽæŽåã³ä¹Ÿç¥ããŠãçŸããçœ
è²çµæ¶ãåŸããèç¹136âãã¢ã»ããããªã«130ã
æ°Ž15åã³é ¢é žïŒã®ç³»ã«ãããããŒãŒã«ã²ã«TLC
ã§ã®Rfå€0.4ïŒåäžã¹ãããïŒã ãαãïŒïŒ ïŒâ60.4ãïŒïŒ£ïŒïŒïŒ ãã¢ã»ãã³ïŒã å®æœäŸ ïŒ nâ²âããã㫠âïŒâãïŒâïŒïŒâãããã
ã·âïŒâã€ã³ããªã«ïŒâïŒâã¢ããâããããª
ãã«ãªãã·ãã¢ã»ããŒã ãäžè¬åŒïŒïŒãïŒC3H7ã ïœ ããã㫠âïŒâãïŒâïŒïŒâããããã·
âïŒâã€ã³ããªã«ïŒâïŒâã¢ããâããããªã
ã«ãªãã·ãã¢ã»ããŒã å®æœäŸ5aïŒã§åŸãâïŒâïŒïŒâãã³ãžã«ãªã
ã·ã«ã«ããã«ãªãã·âïŒâã€ã³ããªã«ïŒâïŒâã
ã³ãžã«ãªãã·ã«ã«ããã«ã¢ããâããããªã³é ž50
ïœïŒ0.1ã¢ã«ïŒããžã¡ãã«ãã«ã ã¢ãã300mlããž
ã·ã¯ãããã·ã«ã¢ãã³20mlãæ²åãããªãŠã ïŒïœ
åã³ã¯ããé ¢é žïœâãããã«12mlã®æ··åç©ãã20
æéæ¹æããå®æœäŸ1bïŒãšåæ§ã«åŠçããã溶
åªãçå»åŸãç²ãªã€ã«ãããã³ãŒã³âãšãŒãã«æ··
液ã溶åºæº¶åªãšããã·ãªã«ã²ã«ã¯ãããã°ã©ãã€
ãŒã«ãã粟補ãããçŽç²ãªãªã€ã«ïŒåç60ïŒ ïŒ
ã¯ããã«ãšã³80ãè»é žãšãã«40åã³è»é žïŒã®ç³»ã«
ãããã·ãªã«ã²ã«TLCã«ãããŠRfïŒ0.5ã®åäžã¹
ãããã®ã¿ãäžããã ãαãïŒïŒ ïŒâ25°ïŒïŒ£ïŒïŒïŒ ããšã¿ããŒã«ïŒã ïœ ïœâããã㫠âïŒâãïŒâïŒïŒâããã
ãã·âïŒâã€ã³ããªã«ïŒâïŒâã¢ããâããã
ãªãã«ãªãã·ãã¢ã»ããŒã 倧æ°å§äžã«äžèšã§åŸãååç©29.5ïœïŒ0.05ã¢
ã«ïŒãã€ãœãããããŒã«500mlã®æº¶æ¶²ãšããïŒïŒ
ãã©ãžãŠã âççŽ 2.5ïœã®ååšäžã«æ°ŽçŽ æ·»å ã
ããçè«éã®æ°ŽçŽ ãåºå®ãããæã觊åªãå»
ãã溶åªãçå»ããé ¢é žãšãã«ã«æº¶è§£ããæ°ŽæŽã
ãã溶åªãçå»ãããã³ãŒã³ã§åçµæ¶ãããçŽç²
ãªç®çç©ãåŸãïŒåç55ïŒ ïŒãèç¹97âã ãαãDïŒâ58.5ãïŒïŒ£ïŒïŒïŒ ãã¢ã»ãã³ïŒã å®æœäŸ ïŒ ïœâãã㫠âïŒâãïŒâïŒïŒâããããã·
âïŒâã€ã³ããªã«ïŒâïŒâã¢ããâããããªã
ã«ãªãã·ãã¢ã»ããŒã ãäžè¬åŒïŒïŒãïŒC4H9ã ïœ ãã㫠âïŒâãïŒâïŒïŒâãã³ãžã«ãªã
ã·ã«ã«ããã«ãªãã·âïŒâã€ã³ããªã«ïŒâïŒâ
ãã³ãžã«ãªãã·ã«ã«ããã«ã¢ããâããããªã
ã«ãªãã·ãã¢ã»ããŒã å®æœäŸïŒïŒã§åŸãâïŒâïŒïŒâãã³ãžã«ãªã
ã·ã«ã«ããã«ãªãã·âïŒâã€ã³ããªã«ïŒâïŒâã
ã³ãžã«ãªãã·ã«ã«ããã«ã¢ããâããããªã³é ž50
ïœïŒ0.1ã¢ã«ïŒããžã¡ãã«ãã«ã ã¢ãã300mlããž
ã·ã¯ãããã·ã«ã¢ãã³20mlãæ²åãããªãŠã ïŒïœ
åã³ã¯ããé ¢é žïœâããã«14.2mlïŒ0.1ã¢ã«ïŒã®
æ··åç©ãã20æéæ¹æããå®æœäŸ1bïŒãšåæ§ã«
åŠçãããåŸããããªã€ã«ïŒåç80ïŒ ïŒã¯ããã«
ãšã³80ãè»é žãšãã«40åã³è»é žïŒã®ç³»ã«ãããã·
ãªã«ã²ã«TLCã«ãããŠRfïŒ0.5ã®åäžã¹ãããã®
ã¿ãäžããã ïœ ïœâãã㫠âïŒâãïŒâïŒïŒâãããã
ã·âïŒâã€ã³ããªã«ïŒâïŒâã¢ããâããããª
ãã«ãªãã·ãã¢ã»ããŒã 倧æ°å§äžã«äžèšã§åŸãååç©37.5ïœïŒ0.057ã¢
ã«ïŒãã€ãœãããããŒã«500mlã®æº¶åªãšããïŒïŒ
ãã©ãžãŠã âççŽ 2.5ïœã®ååšäžã«æ°ŽçŽ æ·»å ã
ããçè«éã®æ°ŽçŽ ãåžåãããæã觊åªãå»
ãã溶åªãçå»ããé ¢é žãšãã«ã«æº¶è§£ããæ°ŽæŽã
ãã溶åªãçå»åŸãç²ãªã€ã«23.5ïœãåŸãããã
ãé ¢é žãšãã«ã«æº¶è§£ããæ°ŽæŽåŸæº¶åªãçå»ããŠã
çŽç²ãªç®çç©ãåŸãïŒåç51ïŒ ïŒãèç¹96âïŒã³
ãã©ãŒïŒããαãïŒïŒ ïŒïŒ2.7ãïŒïŒ£ïŒïŒïŒ ããšã¿ã
ãŒ
ã«ïŒãâ51ãïŒïŒ£ïŒïŒïŒ ãã¢ã»ãã³ïŒã å®æœäŸ ïŒ ïœâãã³ã㫠âïŒâãïŒâïŒïŒâãããã
ã·âïŒâã€ã³ããªã«ïŒâïŒâã¢ããâããããª
ãã«ãªãã·ãã¢ã»ããŒã ãäžè¬åŒïŒïŒãïŒC5H14ã ïœ ïœâãã³ã㫠âïŒâãïŒâïŒïŒâãã³ãž
ã«ãªãã·ã«ã«ããã«ãªãã·âïŒâã€ã³ããªã«ïŒ
âïŒâãã³ãžã«ãªãã·ã«ã«ããã«ã¢ããâãã
ããªãã«ãªãã·ãã¢ã»ããŒã å®æœäŸ5aïŒã§åŸãâïŒâãïŒâïŒïŒâãã³ãž
ã«ãªãã·ã«ã«ããã«ãªãã·âïŒâã€ã³ããªã«ïŒâ
ïŒâãã³ãžã«ãªãã·ã«ã«ããã«ã¢ããâããããª
ã³é ž50ïœïŒ0.1ã¢ã«ïŒããžã¡ãã«ãã«ã ã¢ãã300
mlããžã·ã¯ãããã·ã«ã¢ãã³20mlãæ²åãããªãŠ
ã ïŒïœåã³ã¯ããé ¢é žïœâãã³ãã«16.5mlïŒ0.1
ã¢ã«ïŒã®æ··åç©ãã20æéæ¹æããå®æœäŸ1bïŒ
ãšåæ§ã«åŠçãããç²è£œãªã€ã«ããã³ãŒã³âãšãŒ
ãã«æ··æ¶²ã溶åºæº¶åªãšããã·ãªã«ã²ã«ã«ã©ã ã¯ã
ããã°ã©ãã€ãŒã«ãã粟補ãããçŽç²ãªãªã€ã«ã
åç62ïŒ ã§åŸããããã¯åè¿°ãã溶åªç³»ã«ããã
ã·ãªã«ã²ã«C.C.Mã«ãããŠRfïŒ0.55ã®åäžã¹ãã
ãã®ã¿ãäžããã ïœ ïœâãã³ã㫠âïŒâãïŒâïŒïŒâããã
ãã·âïŒâã€ã³ããªã«ïŒâïŒâã¢ããâããã
ãªãã«ãªãã·ãã¢ã»ããŒã äžèšïœïŒã§åŸãååç©30ïœïŒ0.05ã¢ã«ïŒãã€ãœ
ãããããŒã«400mlã®æº¶æ¶²ãšããïŒïŒ ãã©ãžãŠã
âççŽ 2.5ïœã®ååšäžã«æ°ŽçŽ æ·»å ãããçè«éã®
æ°ŽçŽ ãåžåãããæã觊åªãå»ããèžçºä¹Ÿåº
ããé ¢é žãšãã«ã«æº¶è§£ããæ°ŽæŽããã溶åªãçå»
åŸãç²ãªã€ã«ããã³ãŒã³ããçµæ¶åãããçŽç²ãª
ç®çç©ãåŸãïŒåç45ïŒ ïŒãèç¹97âããαãïŒïŒ ïŒ
â50.5ãïŒïŒ£ïŒïŒïŒ ãã¢ã»ãã³ïŒã å®æœäŸ 10 ïœâããã·ã« âïŒâãïŒâïŒïŒâãããã
ã·âïŒâã€ã³ããªã«ïŒâïŒâã¢ããâããããª
ãã«ãªãã·ãã¢ã»ããŒã ãäžè¬åŒïŒïŒãïŒC6H13ã ïœ ïœâããã·ã« âïŒâãïŒâïŒïŒâãã³ãž
ã«ãªãã·ã«ã«ããã«ãªãã·âïŒâã€ã³ããªã«ïŒ
âïŒâãã³ãžã«ãªãã·ã«ã«ããã«ã¢ããâãã
ããªãã«ãªãã·ãã¢ã»ããŒã å®æœäŸ5aïŒã§åŸãâïŒâãïŒâïŒïŒâãã³ãž
ã«ãªãã·ã«ã«ããã«ãªãã·âïŒâã€ã³ããªã«ïŒâ
ïŒâãã³ã³ãžã«ã«ã«ããã«ã¢ããâããããªã³é ž
50ïœïŒ0.1ã¢ã«ïŒããžã¡ãã«ãã«ã ã¢ãã300mlã
ãžã·ã¯ãããã·ã«ã¢ãã³20mlïŒ0.1ã¢ã«ïŒãæ²åã
ããªãŠã ïŒïœåã³ã¯ããé ¢é žïœâããã·ã«18ïœ
ïŒ0.1ã¢ã«ïŒã®æ··åç©ãã20æéæ¹æããå®æœäŸ
1bïŒãšåæ§ã«åŠçãããç²ãªã€ã«ããã³ãŒã³â
ãšãŒãã«æ··æ¶²ãçšããã·ãªã«ã²ã«ã¯ãããã°ã©ã
ã€ãŒã«ããããçŽç²ãªãã©ã¯ã·ãšã³ã¯66ïŒ ã®åç
ã瀺ããããã¯éåžžã®æº¶åªç³»ã§ã®ã·ãªã«ã²ã«
TLCã§åäžã¹ããããäžããã以äžããããã®
ãŸãŸæ¬¡ã®å·¥çšã«çšããã ïœ ïœâããã·ã« âïŒâãïŒâïŒïŒâããã
ãã·âïŒâã€ã³ããªã«ïŒâïŒâã¢ããâããã
ãªãã«ãªãã·ãã¢ã»ããŒã 倧æ°å§äžã«äžèšã§åŸãååç©20ïœïŒ0.047ã¢
ã«ïŒãã€ãœãããããŒã«500mlã®æº¶æ¶²ãšããïŒïŒ
ãã©ãžãŠã âççŽ 2.5ïœã®ã®ååšäžã«æ°ŽçŽ æ·»å ã
ããçè«éã®æ°ŽçŽ ãåžåãããæã觊åªãå»
ããã¢ã«ã³ãŒã«ãçå»ããé ¢é žãšãã«ã«æº¶è§£ãã
泚æããŠæ°ŽæŽããã溶åªãçå»åŸãã³ãŒã³ã§çµæ¶
åããçœè²çµæ¶ãåŸãïŒåç70ïŒ ïŒãèç¹99â
ïŒã³ãã©ãŒïŒããαãïŒïŒ ïŒâ51ãïŒïŒ£ïŒïŒïŒ ãã¢ã»
ã
ã³ïŒã å®æœäŸ 11 ïœâããã㫠âïŒâãïŒâïŒïŒâãããã
ã·âïŒâã€ã³ããªã«ïŒâïŒâã¢ããâããããª
ãã«ãªãã·ãã¢ã»ããŒã ãäžè¬åŒïŒïŒãïŒC7H15ã ïœ ïœâããã㫠âïŒâãïŒâïŒïŒâãã³ãž
ã«ãªãã·ã«ã«ããã«ãªãã·âïŒâã€ã³ããªã«ïŒ
âïŒâãã³ãžã«ãªãã·ã«ã«ããã«ã¢ããâãã
ããªãã«ãªãã·ãã¢ã»ããŒã å®æœäŸ5aïŒã§åŸãâïŒâïŒïŒâãã³ãžã«ãªã
ã·ã«ã«ããã«ãªãã·âïŒâã€ã³ããªã«ïŒâïŒâã
ã³ãžã«ãªãã·ã«ã«ããã«ã¢ããâããããªã³é ž50
ïœïŒ0.1ã¢ã«ïŒããžã¡ãã«ãã«ã ã¢ãã300mlããž
ã·ã¯ãããã·ã«ã¢ãã³20mlïŒ0.1ã¢ã«ïŒãæ²åãã
ãªãŠã ïŒïœåã³ã¯ããé ¢é žïœâãããã«19.5ïœ
ïŒ0.1ã¢ã«ïŒã®æ··åç©ãã20æéæ¹æããå®æœäŸ
1bïŒãšåæ§ã«åŠçããããã³ãŒã³âãšãŒãã«æ··
液ãçšããã·ãªã«ã²ã«ã¯ãããã°ã©ãã€ãŒã«ãã
粟補åŸãç²ãªã€ã«ãåç71ïŒ ã§åŸããããã¯éåžž
ã®æº¶åªç³»ã§RfïŒ0.55ã®åäžã¹ããããäžããã
ãαãïŒïŒ ïŒâ13ãïŒïŒ£ïŒïŒïŒ ãç¡æ°Žãšã¿ããŒã«ïŒã ïœ ïœâããã㫠âïŒâãïŒâïŒïŒâããã
ãã·âïŒâã€ã³ããªã«ïŒâïŒâã¢ããâããã
ãªãã«ãªãã·ãã¢ã»ããŒã äžèšïœïŒã§åŸãããååç©32ïœïŒ0.05ã¢ã«ïŒã
ïŒïŒ ãã©ãžãŠã âççŽ 2.5ïœã®ååšäžã€ãœããã
ããŒã«400mläžã§æ°ŽçŽ æ·»å ãããçè«éã®æ°ŽçŽ ã
åžåãããæã觊åªãå»ãã溶åªãçå»ãã
åŸãé ¢é žãšãã«ã§æœåºãã次ã«æ°ŽæŽãããé ¢é žãš
ãã«ãçå»åŸãæ®æž£ããã³ãŒã³äžã§åçµæ¶ããŠã
çœè²çµæ¶10ïœãåŸããèç¹99âããαãïŒïŒ ïŒâ50.7
ãïŒïŒ£ïŒïŒïŒ ãã¢ã»ãã³ïŒ å®æœäŸ 12 ïœâãªã¯ã㫠âïŒâãïŒâïŒïŒâãããã
ã·âïŒâã€ã³ããªã«ïŒâïŒâã¢ããâããããª
ãã«ãªãã·ãã¢ã»ããŒã ãäžè¬åŒïŒïŒãïŒC8H17ã ïœ ïœâãªã¯ã㫠âïŒâãïŒâïŒïŒâãã³ãž
ã«ãªãã·ã«ã«ããã«ãªãã·âïŒâã€ã³ããªã«ïŒ
âïŒâãã³ãžã«ãªãã·ã«ã«ããã«ã¢ããâãã
ããªãã«ãªãã·ãã¢ã»ããŒã å®æœäŸ5aïŒã§åŸãããâïŒâïŒïŒâãã³ãžã«
ãªãã·ã«ã«ããã«ãªãã·âïŒâã€ã³ããªã«ïŒâïŒ
âãã³ãžã«ãªãã·ã«ã«ããã«ã¢ããâããããªã³
é ž50ïœïŒ0.1ã¢ã«ïŒããžã¡ãã«ãã«ã ã¢ãã300
mlããžã·ã¯ãããã·ã«ã¢ãã³20mlãæ²åãããªãŠ
ã ïŒïœåã³ã¯ããé ¢é žïœâãªã¯ãã«20.5ïŒ0.1ã¢
ã«ïŒã®æ··åç©ã20æéæ¹æããå®æœäŸ1bïŒã«åŸ
ã€ãŠåŠçããã ç²ãªã€ã«51ïœïŒåç77ïŒ ïŒãåŸããããã¯éåžž
ã®æº¶åªç³»ã§ã®ã·ãªã«ã²ã«TLCã«ãããŠRfïŒ0.6ãš
ããåäžã®ã¹ããããæããŠããããαãïŒïŒ ïŒâ
13.9ãïŒïœïŒïŒïŒ ããšã¿ããŒã«ïŒ ïœ ïœâãªã¯ã㫠âïŒâãïŒâïŒïŒâããã
ãã·âïŒâã€ã³ããªã«ïŒâïŒâã¢ããâããã
ãªãã«ãªãã·ãã¢ã»ããŒã äžèšïœïŒã§åŸãããååç©30ïœïŒ0.045ã¢ã«ïŒ
ãïŒïŒ ãã©ãžãŠã âççŽ 2.5ïœã®ååšäžã€ãœãã
ãããŒã«400mläžã§æ°ŽçŽ æ·»å ãããçè«éã®æ°ŽçŽ
ãåžåãããæã觊åªãå»ãã溶åªãçå»ãã
åŸãé ¢é žãšãã«ã§æœåºãã次ã«æ°ŽæŽããã溶åªã
çå»åŸãæ®æž£ããã³ãŒã³äžã§åçµæ¶ããŠãçœè²çµ
æ¶10.9ïœïŒåç48ïŒ ïŒãåŸããèç¹105âããαãD
ïŒïŒ0.71ãïŒïŒ£ïŒïŒïŒ ãç¡æ°Žãšã¿ããŒã«ïŒãâ52.0
ãïŒïŒ£ïŒïŒïŒ ãç¡æ°Žã¢ã»ãã³ïŒ å®æœäŸ 13 ïœâããã·ã« âïŒâãïŒâïŒïŒâãããã
ã·âïŒâã€ã³ããªã«ïŒâïŒâã¢ããâããããª
ãã«ãªãã·ãã¢ã»ããŒã ãäžè¬åŒïŒïŒãïŒC12H25ã ïœ ïœâããã·ã« âïŒâãïŒâïŒïŒâããã
ãã·âïŒâã€ã³ããªã«ïŒâïŒâã¢ããâããã
ãªãã«ãªãã·ãã¢ã»ããŒã å®æœäŸ5aïŒã§åŸãããâïŒâïŒïŒâãã³ãžã«
ãªãã·ã«ã«ããã«ãªãã·âïŒâã€ã³ããªã«ïŒâïŒ
âãã³ãžã«ãªãã·ã«ã«ããã«ã¢ããâããããªã³
é ž50ïœïŒ0.1ã¢ã«ïŒããžã·ã¯ãããã·ã«ã¢ãã³20
mlãæ²åãããªãŠã ïŒïœãã¯ããé ¢é žïœâããã·
ã«26.4ïœåã³ãžã¡ãã«ãã«ã ã¢ãã300mlã®æ··å
ç©ã20æéæ¹æããå®æœäŸ1bïŒã«åŸã€ãŠåŠçã
ããç²çæç©ãã·ãªã«ã²ã«ã¯ãããã°ã©ãã€ãŒã«
ãã粟補ãããçŽç²ãªãã©ã¯ã·ãšã³ã¯éåžžã®æº¶åª
ç³»ã«ãããTLCã«ãŠåäžã®ã¹ãããã®ã¿ã瀺ã
ãïŒåç80ïŒ ïŒã ïœ ïœâããã·ã« âïŒâãïŒâïŒïŒâããã
ãã·âïŒâã€ã³ããªã«ïŒâïŒâã¢ããâããã
ãªãã«ãªãã·ïŒã¢ã»ããŒã 倧æ°å§äžäžèšã§åŸãããååç©77.4ïœããïŒïŒ
ãã©ãžãŠã âççŽ ïŒïœã®ååšäžã€ãœãããããŒã«
1.5äžã§æ°ŽçŽ æ·»å ãããçè«éã®æ°ŽçŽ ãåžåã
ããæã觊åªãå»ããèžçºä¹Ÿåºããé ¢é žãšãã«
ã§æœåºããæ°ŽæŽããã溶åªãçå»åŸãæ®æž£ããã³
ãŒã³äžã§ïŒååçµæ¶ããŠãçŽç²ãªçæç©ãåç60
ïŒ ã§åŸããèç¹107.5âããαãïŒïŒ ïŒ0.17ãïŒïŒ£ïŒ
ïŒ
ïŒ ããšã¿ããŒã«ïŒãâ42.2ãïŒïŒ£ïŒïŒïŒ ãã¢ã»ã
ã³ïŒã å®æœäŸ 14 ïŒïŒïŒïŒâãžã¡ãã«ïŒâïŒâãã㫠âïŒâ
ãïŒâïŒïŒâããããã·âïŒâã€ã³ããªã«ïŒâ
ïŒâã¢ããâããããªãã«ãªãã·ãã¢ã»ããŒã ãäžè¬åŒïŒïŒã
ã·âïŒâã€ã³ããªã«ïŒâïŒâã¢ããâããããª
ãã«ãªãã·ãã¢ã»ããŒã äžèšã§åŸãèªå°äœ8.8ïœïŒ0.020ã¢ã«ïŒãã€ãœã
ããããŒã«150mläžïŒïŒ ãã©ãžãŠã âççŽ ïŒïœã®
ååšäžã§ãæ°ŽçŽ æ·»å ãããå®æœäŸ1cïŒã«åŸã€ãŠåŠ
çããŠãèç¹93ã94âã®ååç©ãåŸããããã¯å®
æœäŸ1aïŒïŒ1bïŒïŒ1cïŒã«ããã®é åºã§ãåŸã€ãŠåŸ
ããããã®ãšåäžã§ãã€ãã å®æœäŸ ïŒ ãã㫠ïŒïŒ¬âïŒâãïŒâïŒïŒâããããã·
âïŒâã€ã³ããªã«ïŒâïŒâã¢ããâããããªã
ã«ãªãã·ãã¢ã»ããŒã ãäžè¬åŒïŒïŒãïŒC4H9ã ïœ ãã㫠ïŒïŒ¬âïŒâãïŒâïŒïŒâãã³ãžã«
ãªãã·ã«ã«ããã«ãªãã·âïŒâã€ã³ããªã«ïŒâ
ïŒâãã³ãžã«ãªãã·ã«ã«ããã«ã¢ããâããã
ãªãã«ãªãã·ãã¢ã»ããŒã åžžæž©äžãäžèšè©Šè¬ãæ··åããã ïŒïŒ¬âïŒâïŒïŒâãã³ãžã«ãªãã·ã«ã«ããã«
ãªãã·âïŒâã€ã³ããªã«ïŒâïŒâãã³ãžã«ãªãã·
ã«ã«ããã«ã¢ããâããããªã³é žïŒå®æœäŸ1aïŒã§
åŸããã®ïŒ100ïœïŒ0.2ã¢ã«ïŒããžã·ã¯ãããã·ã«
ã¢ãã³40mlïŒ0.2ã¢ã«ïŒãã¯ããé ¢é žããã« 28.3
mlïŒ0.2ã¢ã«ïŒããžã¡ãã«ãã«ã ã¢ãã600mlåã³
æ²åãããªãŠã ïŒïœã 次ãã§æ··åç©ãå®æœäŸ1bïŒãšåæ§ã«ããŠåŠç
ããã ç²è£œç©125ïœãåŸããããã¯ã€ãœãããããŒã«
次ãã§ãšã¿ããŒã«ã§çµæ¶åã粟補ã§ãããããã
ãŠç®çç©ãåŸããèç¹90âïŒã³ãã©ãŒïŒã ïœ ãã㫠ïŒïŒ¬âïŒâãïŒâïŒïŒâãããã
ã·âïŒâã€ã³ããªã«ïŒâïŒâã¢ããâããããª
ãã«ãªãã·ãã¢ã»ããŒã äžèšã§åŸãååç©25ïœããã€ãœãããããŒã«
500mläžã§ïŒïŒ ãã©ãžãŠã âççŽ 2.5ïœã®ååšäžã«
æ°ŽçŽ æ·»å ãããçè«éã®æ°ŽçŽ ãåžåãããæã觊
åªãå»ãã溶åªãçå»ããé ¢é žãšãã«ã«æº¶è§£ã
ããæ°ŽæŽåŸæº¶åªãçå»ããçæç©ãã·ãªã«ã²ã«ã¯
ãããã°ã©ãã€ãŒã«ãã粟補ããç®çç©ãåŸãã
åç50ïŒ ãèç¹90âã å®æœäŸ ïŒ ãªã¯ã㫠ïŒïŒ¬âïŒâãïŒâïŒïŒâãããã
ã·âïŒâã€ã³ããªã«ïŒâïŒâã¢ããâããããª
ãã«ãªãã·ãã¢ã»ããŒã ãäžè¬åŒïŒïŒãïŒC8H17ã ïœ ãªã¯ã㫠ïŒïŒ¬âïŒâãïŒâïŒïŒâãã³ãž
ã«ãªãã·ã«ã«ããã«ãªãã·âïŒâã€ã³ããªã«ïŒ
âïŒâãã³ãžã«ãªãã·ã«ã«ããã«ã¢ããâãã
ããªãã«ãªãã·ãã¢ã»ããŒã ïŒïŒ¬âïŒâïŒïŒâãã³ãžã«ãªãã·ã«ã«ããã«
ãªãã·âïŒâã€ã³ããªã«ïŒâïŒâãã³ãžã«ãªãã·
ã«ã«ããã«ã¢ããâããããªã³é ž100ïœïŒ0.2ã¢
ã«ïŒããžã¡ãã«ãã«ã ã¢ãã600mlããžã·ã¯ããã
ã·ã«ã¢ãã³40mlïŒ0.2ã¢ã«ïŒãæ²åãããªãŠã ïŒïœ
åã³ã¯ããé ¢é žãªã¯ãã«41.3ïœïŒ0.2ã¢ã«ïŒã®æ··
åç©ã20æéæ¹æãã次ãã§å®æœäŸ1bïŒãšåæ§
ã«ããŠåŠçãããçµè£œç©ããã·ã¬ã³ããåçµæ¶ã
ãŠãçŸããçœè²çµæ¶36ïœãåŸããèç¹96âã ïœ ãªã¯ã㫠ïŒïŒ¬âïŒâãïŒâïŒïŒâããã
ãã·âïŒâã€ã³ããªã«ïŒâïŒâã¢ããâããã
ãªãã«ãªãã·ãã¢ã»ããŒã 倧æ°å§äžã«äžèšã§åŸãååç©50ïœïŒ0.075ã¢
ã«ïŒããã€ãœãããããŒã«500mläžïŒïŒ ãã©ãžãŠ
ã âççŽ ïŒïœã®ååšäžã«æ°ŽçŽ æ·»å ãããçè«éã®
æ°ŽçŽ ãæ¶è²»ãããæã觊åªãå»ããèžçºä¹Ÿåº
åŸãé ¢é žãšãã«ã«æº¶è§£ãããææ©å±€ãæ°ŽæŽããæ
æã§åŠçã次ãã§æº¶åªãçå»ãããç²ãªã€ã«ãåŸ
ãããã·ã¯ããããµã³ã§çµæ¶åãããèç¹91âã å®æœäŸ ïŒ ããã·ã« ïŒïŒ¬âïŒâãïŒâïŒïŒâãããã
ã·âïŒâã€ã³ããªã«ïŒâïŒâã¢ããâããããª
ãã«ãªãã·ãã¢ã»ããŒã ãäžè¬åŒïŒïŒãïŒC12H25ã ïœ ããã·ã« ïŒïŒ¬âïŒâãïŒâïŒïŒâãã³ãž
ã«ãªãã·ã«ã«ããã«ãªãã·âïŒâã€ã³ããªã«ïŒ
âïŒâãã³ãžã«ãªãã·ã«ã«ããã«ã¢ããâãã
ããªãã«ãªãã·ãã¢ã»ããŒã ïŒïŒ¬âïŒâïŒïŒâãã³ãžã«ãªãã·ã«ã«ããã«
ãªãã·âïŒâã€ã³ããªã«ïŒâïŒâãã³ãžã«ãªãã·
ã«ã«ããã«ã¢ããâããããªã³é žïŒå®æœäŸ1aïŒã§
åŸããã®ïŒ25ïœïŒ0.05ã¢ã«ïŒããžã¡ãã«ãã«ã ã¢
ãã200mlããžã·ã¯ãããã·ã«ã¢ãã³10mlãæ²å
ãããªãŠã 500mgåã¯ããé ¢é žããã·ã«13.2ïœã
æ··åããæ··åç©ãå®æœäŸ1bïŒãšåæ§ã«ããŠåŠç
ãããçæç©ãã€ãœãããããŒã«âãããµã³æ··æ¶²
ããåçµæ¶ããã ïœ ããã·ã« ïŒïŒ¬âïŒâãïŒâïŒïŒâããã
ãã·âïŒâã€ã³ããªã«ïŒâïŒâã¢ããâããã
ãªãã«ãªãã·ãã¢ã»ããŒã äžèšã§åŸãååç©25ïœããã€ãœãããããŒã«
500mläžã§ïŒïŒ ãã©ãžãŠã âççŽ 2.5ïœã®ååšäžã«
æ°ŽçŽ æ·»å ãããè«çéã®æ°ŽçŽ ãåžåãããæã觊
åªãå»ããèžçºä¹Ÿåºããé ¢é žãšãã«ã«æº¶è§£ãã
æ°ŽæŽãããå¡©é žã§åŠçããããšã«ãããçŽæ¥å¡©é ž
å¡©ãåé¢ã§ãããèç¹122ã124âã å®æœäŸ ïŒ ã¡ã㫠âïŒâãïŒâïŒïŒâããããã·âïŒ
âã€ã³ããªã«ïŒâïŒâã¢ããâããããªãã«ãª
ãã·ãã¢ã»ããŒã ãäžè¬åŒïŒïŒãïŒCH3ã ïœ ïŒ¬âïŒâïŒïŒâãã³ãžã«ãªãã·ã«ã«ããã«ãª
ãã·âïŒâã€ã³ããªã«ïŒâïŒâãã³ãžã«ãªãã·
ã«ã«ããã«ã¢ããâããããªã³é ž çªçŽ é°å²æ°äžãâïŒâããããã·ããªããã
ã¢ã³220ïœãæ°ŽïŒã«æº¶è§£ããã©ã»ãååç©ã«ã€
ãå®æœäŸ1aïŒã§çšããæ¹æ³ã«åŸããã¯ããè»é žã
ã³ãžã«ã§åŠçãããäžèšã«ããç²ãªã€ã«ïŒ93ïŒ ïŒ
ãåŸããç²è£œç©ãâååç©ã«ã€ãçšããæ¹æ³
ã«åŸã粟補ãããçœè²çµæ¶ãåç40ïŒ ã§åŸããè
ç¹145ã146âããαãïŒïŒ ïŒâ7.1ãïŒïŒ£ïŒ0.5ïŒ ãç¡
æ°Žãšã¿ããŒã«ïŒãâ9.9ãïŒïŒ£ïŒïŒïŒ ãã¢ã»ãã³ïŒã ïœ ã¡ã㫠âïŒâãïŒâïŒïŒâãã³ãžã«ãªã
ã·ã«ã«ããã«ãªãã·âïŒâã€ã³ããªã«ïŒâïŒâ
ãã³ãžã«ãªãã·ã«ã«ããã«ã¢ããâããããªã
ã«ãªãã·ãã¢ã»ããŒã âïŒâïŒïŒâãã³ãžã«ãªãã·ã«ã«ããã«ãªã
ã·âïŒâã€ã³ããªã«ïŒâïŒâãã³ãžã«ãªãã·ã«ã«
ããã«ã¢ããâããããªã³é žïŒå®æœäŸ5aïŒã§åŸã
ãã®ïŒ50ïœïŒ0.1ã¢ã«ïŒããžã¡ãã«ãã«ã ã¢ãã
300mlããžã·ã¯ãããã·ã«ã¢ãã³20mlãæ²åãã
ãªãŠã ïŒïœåã³ã¯ããé ¢é žã¡ãã«11ïœïŒ0.1ã¢
ã«ïŒã®æ··åç©ã20æéæ¹æããå®æœäŸ1bïŒãšå
æ§ã«ããŠåŠçããã溶åªãçå»åŸããã³ãŒã³âãš
ãŒãã«æ··æ¶²ãå±é溶åªãšããŠã·ãªã«ã²ã«ã¯ããã
ã°ã©ãã€ãŒã«ãã粟補ãããçŽç²ãªãªã€ã«ã¯ãã
ã«ãšã³80ãè»é žãšãã«40åã³è»é žïŒã®ç³»ã«ããã
ã·ãªã«æ¿äžC.C.Mã«ãããŠRfïŒ0.6ã®åäžã¹ãã
ãã®ã¿ãæããŠãããããããã®ãŸãŸäžèšå·¥çšã«
çšããã ïœ ã¡ã㫠âïŒâãïŒâïŒïŒâããããã·â
ïŒâã€ã³ããªã«ïŒâïŒâã¢ããâããããªãã«
ãªãã·ãã¢ã»ããŒã äžèšååç©28ïœïŒ0.05ã¢ã«ïŒãã€ãœãããããŒ
ã«æº¶æ¶²ãšããïŒïŒ ãã©ãžãŠã âççŽ 2.5ïœã®ååš
äžã«æ°ŽçŽ æ·»å ãããçè«éã®æ°ŽçŽ ãåºå®ããã
æã觊åªãå»ãã溶åªãçå»ããé ¢é žãšãã«ã§
æœåºããæ°ŽæŽãã次ãã§æº¶åªçå»ã®åŸãã³ãŒã³ã§
åçµæ¶ãããçœè²çµæ¶ïŒåç50ïŒ ïŒãåŸããèç¹
125âïŒã³ãã©ãŒïŒããαãïŒïŒ ïŒâ59ãïŒïŒ£ïŒïŒïŒ
ã
ã¢ã»ãã³ïŒã å®æœäŸ ïŒ ãšã㫠âïŒâãïŒâïŒïŒâããããã·âïŒ
âã€ã³ããªã«ïŒâïŒâã¢ããããããªãã«ãªã
ã·ãã¢ã»ããŒã ãäžè¬åŒïŒïŒãïŒC2H5ã ïœ ãšã㫠âïŒâãïŒâïŒïŒâãã³ãžã«ãªã
ã·ã«ã«ããã«ãªãã·âïŒâã€ã³ããªã«ïŒâïŒâ
ãã³ãžã«ãªãã·ã«ã«ããã«ã¢ããâããããªã
ã«ãªãã·ãã¢ã»ããŒã å®æœäŸ5aïŒã§åŸãâïŒâïŒïŒâãã³ãžã«ãªã
ã·ã«ã«ããã«ãªãã·âïŒâã€ã³ããªã«ïŒâïŒâã
ã³ãžã«ãªãã·ã«ã«ããã«ã¢ããâããããªã³é ž50
ïœïŒ0.1ã¢ã«ïŒããžã¡ãã«ãã«ã ã¢ãã300mlããž
ã·ã¯ãããã·ã«ã¢ãã³20mlãæ²åãããªãŠã ïŒïœ
åã³ã¯ããé ¢é žãšãã«10.5mlã®æ··åç©ãã20æé
æ¹æããå®æœäŸ1bïŒãšåæ§ã«åŠçããã溶åªã
å®å šã«çå»ããŠãè€è²ãªã€ã«51ïœãåŸããããã¯
ãã«ãšã³80ãè»é žãšãã«40åã³è»é žïŒã®ç³»ã«ãã
ããâãŒã«ã²ã«TICã«ãããŠRfïŒ0.6ã®åäžã¹ã
ããã®ã¿ãäžãããçæç©ã®IRåæçµæã§ã¯ã
3400cm-1åã³1740cm-1ã«ç¹åŸŽçãªãã³ããèªãã
ããã ãαãïŒïŒ ïŒâ22.55ãïŒïŒ£ïŒïŒïŒ ããšã¿ããŒã«ïŒ ïœ ãšã㫠âïŒâãïŒâïŒïŒâããããã·â
ïŒâã€ã³ããªã«ïŒâïŒâã¢ããâããããªãã«
ãªãã·ãã¢ã»ããŒã 倧æ°å§äžã«äžèšã§åŸãååç©49ïœïŒ0.0854ã¢
ã«ïŒãã€ãœãããããŒã«ã®æº¶æ¶²ãšããïŒïŒ ãã©ãž
ãŠã âççŽ 2.5ïœã®ååšäžã«æ°ŽçŽ æ·»å ãããçè«
éã®æ°ŽçŽ ãåºå®ãããæã觊åªãå»ãã溶åªã
çå»ããé ¢é žãšãã«äžã«æº¶è§£ããæ°ŽæŽåŸææã§åŠ
çã溶åªãçå»ãããæ®æž£ãå床ã€ãœãããããŒ
ã«äžã®æº¶è§£ããå¡©é žå¡©ãšãïŒããã¯å·æã§çµæ¶å
ããïŒãéããæ°ŽæŽãã也ç¥ãããå¡©é žå¡©20.8
ïœïŒåç71ïŒ ïŒãåŸããèç¹257ã260âã è©²å¡©é žå¡©ã¯åžéã¢ã³ã¢ãã¢æ°Žã§åŠçããå¡©åºãš
ãªãããããéãæ°ŽæŽåã³ä¹Ÿç¥ããŠãçŸããçœ
è²çµæ¶ãåŸããèç¹136âãã¢ã»ããããªã«130ã
æ°Ž15åã³é ¢é žïŒã®ç³»ã«ãããããŒãŒã«ã²ã«TLC
ã§ã®Rfå€0.4ïŒåäžã¹ãããïŒã ãαãïŒïŒ ïŒâ60.4ãïŒïŒ£ïŒïŒïŒ ãã¢ã»ãã³ïŒã å®æœäŸ ïŒ nâ²âããã㫠âïŒâãïŒâïŒïŒâãããã
ã·âïŒâã€ã³ããªã«ïŒâïŒâã¢ããâããããª
ãã«ãªãã·ãã¢ã»ããŒã ãäžè¬åŒïŒïŒãïŒC3H7ã ïœ ããã㫠âïŒâãïŒâïŒïŒâããããã·
âïŒâã€ã³ããªã«ïŒâïŒâã¢ããâããããªã
ã«ãªãã·ãã¢ã»ããŒã å®æœäŸ5aïŒã§åŸãâïŒâïŒïŒâãã³ãžã«ãªã
ã·ã«ã«ããã«ãªãã·âïŒâã€ã³ããªã«ïŒâïŒâã
ã³ãžã«ãªãã·ã«ã«ããã«ã¢ããâããããªã³é ž50
ïœïŒ0.1ã¢ã«ïŒããžã¡ãã«ãã«ã ã¢ãã300mlããž
ã·ã¯ãããã·ã«ã¢ãã³20mlãæ²åãããªãŠã ïŒïœ
åã³ã¯ããé ¢é žïœâãããã«12mlã®æ··åç©ãã20
æéæ¹æããå®æœäŸ1bïŒãšåæ§ã«åŠçããã溶
åªãçå»åŸãç²ãªã€ã«ãããã³ãŒã³âãšãŒãã«æ··
液ã溶åºæº¶åªãšããã·ãªã«ã²ã«ã¯ãããã°ã©ãã€
ãŒã«ãã粟補ãããçŽç²ãªãªã€ã«ïŒåç60ïŒ ïŒ
ã¯ããã«ãšã³80ãè»é žãšãã«40åã³è»é žïŒã®ç³»ã«
ãããã·ãªã«ã²ã«TLCã«ãããŠRfïŒ0.5ã®åäžã¹
ãããã®ã¿ãäžããã ãαãïŒïŒ ïŒâ25°ïŒïŒ£ïŒïŒïŒ ããšã¿ããŒã«ïŒã ïœ ïœâããã㫠âïŒâãïŒâïŒïŒâããã
ãã·âïŒâã€ã³ããªã«ïŒâïŒâã¢ããâããã
ãªãã«ãªãã·ãã¢ã»ããŒã 倧æ°å§äžã«äžèšã§åŸãååç©29.5ïœïŒ0.05ã¢
ã«ïŒãã€ãœãããããŒã«500mlã®æº¶æ¶²ãšããïŒïŒ
ãã©ãžãŠã âççŽ 2.5ïœã®ååšäžã«æ°ŽçŽ æ·»å ã
ããçè«éã®æ°ŽçŽ ãåºå®ãããæã觊åªãå»
ãã溶åªãçå»ããé ¢é žãšãã«ã«æº¶è§£ããæ°ŽæŽã
ãã溶åªãçå»ãããã³ãŒã³ã§åçµæ¶ãããçŽç²
ãªç®çç©ãåŸãïŒåç55ïŒ ïŒãèç¹97âã ãαãDïŒâ58.5ãïŒïŒ£ïŒïŒïŒ ãã¢ã»ãã³ïŒã å®æœäŸ ïŒ ïœâãã㫠âïŒâãïŒâïŒïŒâããããã·
âïŒâã€ã³ããªã«ïŒâïŒâã¢ããâããããªã
ã«ãªãã·ãã¢ã»ããŒã ãäžè¬åŒïŒïŒãïŒC4H9ã ïœ ãã㫠âïŒâãïŒâïŒïŒâãã³ãžã«ãªã
ã·ã«ã«ããã«ãªãã·âïŒâã€ã³ããªã«ïŒâïŒâ
ãã³ãžã«ãªãã·ã«ã«ããã«ã¢ããâããããªã
ã«ãªãã·ãã¢ã»ããŒã å®æœäŸïŒïŒã§åŸãâïŒâïŒïŒâãã³ãžã«ãªã
ã·ã«ã«ããã«ãªãã·âïŒâã€ã³ããªã«ïŒâïŒâã
ã³ãžã«ãªãã·ã«ã«ããã«ã¢ããâããããªã³é ž50
ïœïŒ0.1ã¢ã«ïŒããžã¡ãã«ãã«ã ã¢ãã300mlããž
ã·ã¯ãããã·ã«ã¢ãã³20mlãæ²åãããªãŠã ïŒïœ
åã³ã¯ããé ¢é žïœâããã«14.2mlïŒ0.1ã¢ã«ïŒã®
æ··åç©ãã20æéæ¹æããå®æœäŸ1bïŒãšåæ§ã«
åŠçãããåŸããããªã€ã«ïŒåç80ïŒ ïŒã¯ããã«
ãšã³80ãè»é žãšãã«40åã³è»é žïŒã®ç³»ã«ãããã·
ãªã«ã²ã«TLCã«ãããŠRfïŒ0.5ã®åäžã¹ãããã®
ã¿ãäžããã ïœ ïœâãã㫠âïŒâãïŒâïŒïŒâãããã
ã·âïŒâã€ã³ããªã«ïŒâïŒâã¢ããâããããª
ãã«ãªãã·ãã¢ã»ããŒã 倧æ°å§äžã«äžèšã§åŸãååç©37.5ïœïŒ0.057ã¢
ã«ïŒãã€ãœãããããŒã«500mlã®æº¶åªãšããïŒïŒ
ãã©ãžãŠã âççŽ 2.5ïœã®ååšäžã«æ°ŽçŽ æ·»å ã
ããçè«éã®æ°ŽçŽ ãåžåãããæã觊åªãå»
ãã溶åªãçå»ããé ¢é žãšãã«ã«æº¶è§£ããæ°ŽæŽã
ãã溶åªãçå»åŸãç²ãªã€ã«23.5ïœãåŸãããã
ãé ¢é žãšãã«ã«æº¶è§£ããæ°ŽæŽåŸæº¶åªãçå»ããŠã
çŽç²ãªç®çç©ãåŸãïŒåç51ïŒ ïŒãèç¹96âïŒã³
ãã©ãŒïŒããαãïŒïŒ ïŒïŒ2.7ãïŒïŒ£ïŒïŒïŒ ããšã¿ã
ãŒ
ã«ïŒãâ51ãïŒïŒ£ïŒïŒïŒ ãã¢ã»ãã³ïŒã å®æœäŸ ïŒ ïœâãã³ã㫠âïŒâãïŒâïŒïŒâãããã
ã·âïŒâã€ã³ããªã«ïŒâïŒâã¢ããâããããª
ãã«ãªãã·ãã¢ã»ããŒã ãäžè¬åŒïŒïŒãïŒC5H14ã ïœ ïœâãã³ã㫠âïŒâãïŒâïŒïŒâãã³ãž
ã«ãªãã·ã«ã«ããã«ãªãã·âïŒâã€ã³ããªã«ïŒ
âïŒâãã³ãžã«ãªãã·ã«ã«ããã«ã¢ããâãã
ããªãã«ãªãã·ãã¢ã»ããŒã å®æœäŸ5aïŒã§åŸãâïŒâãïŒâïŒïŒâãã³ãž
ã«ãªãã·ã«ã«ããã«ãªãã·âïŒâã€ã³ããªã«ïŒâ
ïŒâãã³ãžã«ãªãã·ã«ã«ããã«ã¢ããâããããª
ã³é ž50ïœïŒ0.1ã¢ã«ïŒããžã¡ãã«ãã«ã ã¢ãã300
mlããžã·ã¯ãããã·ã«ã¢ãã³20mlãæ²åãããªãŠ
ã ïŒïœåã³ã¯ããé ¢é žïœâãã³ãã«16.5mlïŒ0.1
ã¢ã«ïŒã®æ··åç©ãã20æéæ¹æããå®æœäŸ1bïŒ
ãšåæ§ã«åŠçãããç²è£œãªã€ã«ããã³ãŒã³âãšãŒ
ãã«æ··æ¶²ã溶åºæº¶åªãšããã·ãªã«ã²ã«ã«ã©ã ã¯ã
ããã°ã©ãã€ãŒã«ãã粟補ãããçŽç²ãªãªã€ã«ã
åç62ïŒ ã§åŸããããã¯åè¿°ãã溶åªç³»ã«ããã
ã·ãªã«ã²ã«C.C.Mã«ãããŠRfïŒ0.55ã®åäžã¹ãã
ãã®ã¿ãäžããã ïœ ïœâãã³ã㫠âïŒâãïŒâïŒïŒâããã
ãã·âïŒâã€ã³ããªã«ïŒâïŒâã¢ããâããã
ãªãã«ãªãã·ãã¢ã»ããŒã äžèšïœïŒã§åŸãååç©30ïœïŒ0.05ã¢ã«ïŒãã€ãœ
ãããããŒã«400mlã®æº¶æ¶²ãšããïŒïŒ ãã©ãžãŠã
âççŽ 2.5ïœã®ååšäžã«æ°ŽçŽ æ·»å ãããçè«éã®
æ°ŽçŽ ãåžåãããæã觊åªãå»ããèžçºä¹Ÿåº
ããé ¢é žãšãã«ã«æº¶è§£ããæ°ŽæŽããã溶åªãçå»
åŸãç²ãªã€ã«ããã³ãŒã³ããçµæ¶åãããçŽç²ãª
ç®çç©ãåŸãïŒåç45ïŒ ïŒãèç¹97âããαãïŒïŒ ïŒ
â50.5ãïŒïŒ£ïŒïŒïŒ ãã¢ã»ãã³ïŒã å®æœäŸ 10 ïœâããã·ã« âïŒâãïŒâïŒïŒâãããã
ã·âïŒâã€ã³ããªã«ïŒâïŒâã¢ããâããããª
ãã«ãªãã·ãã¢ã»ããŒã ãäžè¬åŒïŒïŒãïŒC6H13ã ïœ ïœâããã·ã« âïŒâãïŒâïŒïŒâãã³ãž
ã«ãªãã·ã«ã«ããã«ãªãã·âïŒâã€ã³ããªã«ïŒ
âïŒâãã³ãžã«ãªãã·ã«ã«ããã«ã¢ããâãã
ããªãã«ãªãã·ãã¢ã»ããŒã å®æœäŸ5aïŒã§åŸãâïŒâãïŒâïŒïŒâãã³ãž
ã«ãªãã·ã«ã«ããã«ãªãã·âïŒâã€ã³ããªã«ïŒâ
ïŒâãã³ã³ãžã«ã«ã«ããã«ã¢ããâããããªã³é ž
50ïœïŒ0.1ã¢ã«ïŒããžã¡ãã«ãã«ã ã¢ãã300mlã
ãžã·ã¯ãããã·ã«ã¢ãã³20mlïŒ0.1ã¢ã«ïŒãæ²åã
ããªãŠã ïŒïœåã³ã¯ããé ¢é žïœâããã·ã«18ïœ
ïŒ0.1ã¢ã«ïŒã®æ··åç©ãã20æéæ¹æããå®æœäŸ
1bïŒãšåæ§ã«åŠçãããç²ãªã€ã«ããã³ãŒã³â
ãšãŒãã«æ··æ¶²ãçšããã·ãªã«ã²ã«ã¯ãããã°ã©ã
ã€ãŒã«ããããçŽç²ãªãã©ã¯ã·ãšã³ã¯66ïŒ ã®åç
ã瀺ããããã¯éåžžã®æº¶åªç³»ã§ã®ã·ãªã«ã²ã«
TLCã§åäžã¹ããããäžããã以äžããããã®
ãŸãŸæ¬¡ã®å·¥çšã«çšããã ïœ ïœâããã·ã« âïŒâãïŒâïŒïŒâããã
ãã·âïŒâã€ã³ããªã«ïŒâïŒâã¢ããâããã
ãªãã«ãªãã·ãã¢ã»ããŒã 倧æ°å§äžã«äžèšã§åŸãååç©20ïœïŒ0.047ã¢
ã«ïŒãã€ãœãããããŒã«500mlã®æº¶æ¶²ãšããïŒïŒ
ãã©ãžãŠã âççŽ 2.5ïœã®ã®ååšäžã«æ°ŽçŽ æ·»å ã
ããçè«éã®æ°ŽçŽ ãåžåãããæã觊åªãå»
ããã¢ã«ã³ãŒã«ãçå»ããé ¢é žãšãã«ã«æº¶è§£ãã
泚æããŠæ°ŽæŽããã溶åªãçå»åŸãã³ãŒã³ã§çµæ¶
åããçœè²çµæ¶ãåŸãïŒåç70ïŒ ïŒãèç¹99â
ïŒã³ãã©ãŒïŒããαãïŒïŒ ïŒâ51ãïŒïŒ£ïŒïŒïŒ ãã¢ã»
ã
ã³ïŒã å®æœäŸ 11 ïœâããã㫠âïŒâãïŒâïŒïŒâãããã
ã·âïŒâã€ã³ããªã«ïŒâïŒâã¢ããâããããª
ãã«ãªãã·ãã¢ã»ããŒã ãäžè¬åŒïŒïŒãïŒC7H15ã ïœ ïœâããã㫠âïŒâãïŒâïŒïŒâãã³ãž
ã«ãªãã·ã«ã«ããã«ãªãã·âïŒâã€ã³ããªã«ïŒ
âïŒâãã³ãžã«ãªãã·ã«ã«ããã«ã¢ããâãã
ããªãã«ãªãã·ãã¢ã»ããŒã å®æœäŸ5aïŒã§åŸãâïŒâïŒïŒâãã³ãžã«ãªã
ã·ã«ã«ããã«ãªãã·âïŒâã€ã³ããªã«ïŒâïŒâã
ã³ãžã«ãªãã·ã«ã«ããã«ã¢ããâããããªã³é ž50
ïœïŒ0.1ã¢ã«ïŒããžã¡ãã«ãã«ã ã¢ãã300mlããž
ã·ã¯ãããã·ã«ã¢ãã³20mlïŒ0.1ã¢ã«ïŒãæ²åãã
ãªãŠã ïŒïœåã³ã¯ããé ¢é žïœâãããã«19.5ïœ
ïŒ0.1ã¢ã«ïŒã®æ··åç©ãã20æéæ¹æããå®æœäŸ
1bïŒãšåæ§ã«åŠçããããã³ãŒã³âãšãŒãã«æ··
液ãçšããã·ãªã«ã²ã«ã¯ãããã°ã©ãã€ãŒã«ãã
粟補åŸãç²ãªã€ã«ãåç71ïŒ ã§åŸããããã¯éåžž
ã®æº¶åªç³»ã§RfïŒ0.55ã®åäžã¹ããããäžããã
ãαãïŒïŒ ïŒâ13ãïŒïŒ£ïŒïŒïŒ ãç¡æ°Žãšã¿ããŒã«ïŒã ïœ ïœâããã㫠âïŒâãïŒâïŒïŒâããã
ãã·âïŒâã€ã³ããªã«ïŒâïŒâã¢ããâããã
ãªãã«ãªãã·ãã¢ã»ããŒã äžèšïœïŒã§åŸãããååç©32ïœïŒ0.05ã¢ã«ïŒã
ïŒïŒ ãã©ãžãŠã âççŽ 2.5ïœã®ååšäžã€ãœããã
ããŒã«400mläžã§æ°ŽçŽ æ·»å ãããçè«éã®æ°ŽçŽ ã
åžåãããæã觊åªãå»ãã溶åªãçå»ãã
åŸãé ¢é žãšãã«ã§æœåºãã次ã«æ°ŽæŽãããé ¢é žãš
ãã«ãçå»åŸãæ®æž£ããã³ãŒã³äžã§åçµæ¶ããŠã
çœè²çµæ¶10ïœãåŸããèç¹99âããαãïŒïŒ ïŒâ50.7
ãïŒïŒ£ïŒïŒïŒ ãã¢ã»ãã³ïŒ å®æœäŸ 12 ïœâãªã¯ã㫠âïŒâãïŒâïŒïŒâãããã
ã·âïŒâã€ã³ããªã«ïŒâïŒâã¢ããâããããª
ãã«ãªãã·ãã¢ã»ããŒã ãäžè¬åŒïŒïŒãïŒC8H17ã ïœ ïœâãªã¯ã㫠âïŒâãïŒâïŒïŒâãã³ãž
ã«ãªãã·ã«ã«ããã«ãªãã·âïŒâã€ã³ããªã«ïŒ
âïŒâãã³ãžã«ãªãã·ã«ã«ããã«ã¢ããâãã
ããªãã«ãªãã·ãã¢ã»ããŒã å®æœäŸ5aïŒã§åŸãããâïŒâïŒïŒâãã³ãžã«
ãªãã·ã«ã«ããã«ãªãã·âïŒâã€ã³ããªã«ïŒâïŒ
âãã³ãžã«ãªãã·ã«ã«ããã«ã¢ããâããããªã³
é ž50ïœïŒ0.1ã¢ã«ïŒããžã¡ãã«ãã«ã ã¢ãã300
mlããžã·ã¯ãããã·ã«ã¢ãã³20mlãæ²åãããªãŠ
ã ïŒïœåã³ã¯ããé ¢é žïœâãªã¯ãã«20.5ïŒ0.1ã¢
ã«ïŒã®æ··åç©ã20æéæ¹æããå®æœäŸ1bïŒã«åŸ
ã€ãŠåŠçããã ç²ãªã€ã«51ïœïŒåç77ïŒ ïŒãåŸããããã¯éåžž
ã®æº¶åªç³»ã§ã®ã·ãªã«ã²ã«TLCã«ãããŠRfïŒ0.6ãš
ããåäžã®ã¹ããããæããŠããããαãïŒïŒ ïŒâ
13.9ãïŒïœïŒïŒïŒ ããšã¿ããŒã«ïŒ ïœ ïœâãªã¯ã㫠âïŒâãïŒâïŒïŒâããã
ãã·âïŒâã€ã³ããªã«ïŒâïŒâã¢ããâããã
ãªãã«ãªãã·ãã¢ã»ããŒã äžèšïœïŒã§åŸãããååç©30ïœïŒ0.045ã¢ã«ïŒ
ãïŒïŒ ãã©ãžãŠã âççŽ 2.5ïœã®ååšäžã€ãœãã
ãããŒã«400mläžã§æ°ŽçŽ æ·»å ãããçè«éã®æ°ŽçŽ
ãåžåãããæã觊åªãå»ãã溶åªãçå»ãã
åŸãé ¢é žãšãã«ã§æœåºãã次ã«æ°ŽæŽããã溶åªã
çå»åŸãæ®æž£ããã³ãŒã³äžã§åçµæ¶ããŠãçœè²çµ
æ¶10.9ïœïŒåç48ïŒ ïŒãåŸããèç¹105âããαãD
ïŒïŒ0.71ãïŒïŒ£ïŒïŒïŒ ãç¡æ°Žãšã¿ããŒã«ïŒãâ52.0
ãïŒïŒ£ïŒïŒïŒ ãç¡æ°Žã¢ã»ãã³ïŒ å®æœäŸ 13 ïœâããã·ã« âïŒâãïŒâïŒïŒâãããã
ã·âïŒâã€ã³ããªã«ïŒâïŒâã¢ããâããããª
ãã«ãªãã·ãã¢ã»ããŒã ãäžè¬åŒïŒïŒãïŒC12H25ã ïœ ïœâããã·ã« âïŒâãïŒâïŒïŒâããã
ãã·âïŒâã€ã³ããªã«ïŒâïŒâã¢ããâããã
ãªãã«ãªãã·ãã¢ã»ããŒã å®æœäŸ5aïŒã§åŸãããâïŒâïŒïŒâãã³ãžã«
ãªãã·ã«ã«ããã«ãªãã·âïŒâã€ã³ããªã«ïŒâïŒ
âãã³ãžã«ãªãã·ã«ã«ããã«ã¢ããâããããªã³
é ž50ïœïŒ0.1ã¢ã«ïŒããžã·ã¯ãããã·ã«ã¢ãã³20
mlãæ²åãããªãŠã ïŒïœãã¯ããé ¢é žïœâããã·
ã«26.4ïœåã³ãžã¡ãã«ãã«ã ã¢ãã300mlã®æ··å
ç©ã20æéæ¹æããå®æœäŸ1bïŒã«åŸã€ãŠåŠçã
ããç²çæç©ãã·ãªã«ã²ã«ã¯ãããã°ã©ãã€ãŒã«
ãã粟補ãããçŽç²ãªãã©ã¯ã·ãšã³ã¯éåžžã®æº¶åª
ç³»ã«ãããTLCã«ãŠåäžã®ã¹ãããã®ã¿ã瀺ã
ãïŒåç80ïŒ ïŒã ïœ ïœâããã·ã« âïŒâãïŒâïŒïŒâããã
ãã·âïŒâã€ã³ããªã«ïŒâïŒâã¢ããâããã
ãªãã«ãªãã·ïŒã¢ã»ããŒã 倧æ°å§äžäžèšã§åŸãããååç©77.4ïœããïŒïŒ
ãã©ãžãŠã âççŽ ïŒïœã®ååšäžã€ãœãããããŒã«
1.5äžã§æ°ŽçŽ æ·»å ãããçè«éã®æ°ŽçŽ ãåžåã
ããæã觊åªãå»ããèžçºä¹Ÿåºããé ¢é žãšãã«
ã§æœåºããæ°ŽæŽããã溶åªãçå»åŸãæ®æž£ããã³
ãŒã³äžã§ïŒååçµæ¶ããŠãçŽç²ãªçæç©ãåç60
ïŒ ã§åŸããèç¹107.5âããαãïŒïŒ ïŒ0.17ãïŒïŒ£ïŒ
ïŒ
ïŒ ããšã¿ããŒã«ïŒãâ42.2ãïŒïŒ£ïŒïŒïŒ ãã¢ã»ã
ã³ïŒã å®æœäŸ 14 ïŒïŒïŒïŒâãžã¡ãã«ïŒâïŒâãã㫠âïŒâ
ãïŒâïŒïŒâããããã·âïŒâã€ã³ããªã«ïŒâ
ïŒâã¢ããâããããªãã«ãªãã·ãã¢ã»ããŒã ãäžè¬åŒïŒïŒã
ãåŒãã
ïœ ã¯ããé
¢é
žïŒïŒïŒïŒâãžã¡ãã«ïŒâïŒâãã
ã«ïŒïŒïŒâãžã¡ãã«âïŒâãã¿ããŒã«40.9ïœ
ïŒ0.4ã¢ã«ïŒåã³ããªãšãã«ã¢ãã³58mlïŒ0.42ã¢
ã«ïŒã®æ··åç©ã«ãå¡©åã¯ããã¢ã»ãã«47.5ïœ
ïŒ0.42ã¢ã«ïŒãåŸã ã«å ãããåå¿æ··åç©ã«é ž
ã¯ãã©ã€ããæµããŠããéããã10âã«ä¿ã¡ã
ãã®åŸåžžæž©ã§ãçŽïŒæéæ¹æãããéåã³ã
ãªãšãã«ã¢ãã³å¡©é žå¡©ã®ãšãŒãã«æº¶æ¶²ã§æŽæµ
åŸã該溶液ãæ°ŽæŽãã次ãã§ç¡«é žãããªãŠã äž
ã§ä¹Ÿç¥ãããã溶åªãçå»ããç空äžã«èžçã
ãŠçŽç²ãªæ¶²äœ64ïœïŒåç89ïŒ ïŒãåŸãã沞ç¹79
ã81âïŒ20mmHgã ïœ ïŒïŒïŒïŒâãžã¡ãã«ïŒâïŒâãã㫠âïŒ
âãïŒâïŒïŒâãã³ãžã«ãªãã·ã«ã«ããã«ãªã
ã·âïŒâã€ã³ããªã«ïŒâïŒâãã³ãžã«ãªãã·ã«
ã«ããã«ã¢ããâããããªãã«ãªãã·ãã¢ã»ã
ãŒã âïŒâïŒïŒâãã³ãžã«ãªãã·ã«ã«ããã«ãªã
ã·âïŒâã€ã³ããªã«ïŒâïŒâãã³ãžã«ãªãã·ã«ã«
ããã«ã¢ããâããããªã³é ž50ïœïŒ0.1ã¢ã«ïŒããž
ã·ã¯ãããã·ã«ã¢ãã³20mlïŒ0.1ã¢ã«ïŒãæ²åãã
ãªãŠã ïŒïœãã¯ããé ¢é žïŒïŒïŒïŒâãžã¡ãã«ïŒâ
ïŒâããã«17.75ïœïŒ0.1ã¢ã«ïŒåã³ãžã¡ãã«ãã«
ã ã¢ãã300mlã®æ··åç©ã20æéæ¹æããå®æœäŸ
1bïŒã«åŸã€ãŠåŠçãããç²çæç©ãå±é溶åªãš
ããŠãã«ãšã³âãšãŒãã«ïŒïŒïŒïŒïŒãçšããã·ãª
ã«ã²ã«ã¯ãããã°ã©ãã€ãŒã«ãã粟補ããŠãçŽç²
ãªãªã€ã«ãåç76ïŒ ã§åŸããããã¯çš®ã ã®ç³»ã«ã
ããããŒãŒã«ã²ã«äžã®TLCã«ãããŠåäžã®ã¹ã
ãããæããŠãããRfïŒ0.6ïŒã¯ãããã«ã 70ã
ãšã¿ããŒã«30åã³è»é žïŒãããªãæ··åç©ïŒããαã
ïŒïŒ â7.28ãïŒïŒ£ïŒïŒïŒ ããšã¿ããŒã«ïŒ ïœ ïŒïŒïŒïŒâãžã¡ãã«ïŒâïŒâãã㫠âïŒ
âãïŒâïŒïŒâããããã·âïŒâã€ã³ããªã«ïŒ
âïŒâã¢ããâããããªãã«ãªãã·ãã¢ã»ããŒ
ã 倧æ°å§äžäžèšã§åŸãããååç©48ïœããïŒïŒ ã
ã©ãžãŠã âççŽ 2.5ïœã®ååšäžã€ãœãããããŒã«
ïŒäžã§æ°ŽçŽ æ·»å ãããçè«éã®æ°ŽçŽ ãåžåãã
ãæã觊åªãå»ããèžçºä¹Ÿåºããé ¢é žãšãã«ã§
æœåºããæ°ŽæŽããã溶åªãçå»åŸãæ®æž£ããã³ãŒ
ã³ã§åçµæ¶ããŠãçœè²çµæ¶14.5ïœïŒåç53ïŒ ïŒã
åŸããèç¹106ã107âããαãïŒïŒ ïŒïŒ7.48ãïŒïŒ£ïŒ
ïŒïŒ ãã¢ã»ãã³ïŒ å®æœäŸ 15 ïŒâã¢ããã³ãã«âã¡ãã« ïŒâãïŒâïŒïŒâ
ããããã·âïŒâã€ã³ããªã«ïŒïŒâïŒâã¢ãã
âããããªãã«ãªãã·ãã¢ã»ããŒã ãäžè¬åŒïŒïŒã
ã«ïŒïŒïŒâãžã¡ãã«âïŒâãã¿ããŒã«40.9ïœ
ïŒ0.4ã¢ã«ïŒåã³ããªãšãã«ã¢ãã³58mlïŒ0.42ã¢
ã«ïŒã®æ··åç©ã«ãå¡©åã¯ããã¢ã»ãã«47.5ïœ
ïŒ0.42ã¢ã«ïŒãåŸã ã«å ãããåå¿æ··åç©ã«é ž
ã¯ãã©ã€ããæµããŠããéããã10âã«ä¿ã¡ã
ãã®åŸåžžæž©ã§ãçŽïŒæéæ¹æãããéåã³ã
ãªãšãã«ã¢ãã³å¡©é žå¡©ã®ãšãŒãã«æº¶æ¶²ã§æŽæµ
åŸã該溶液ãæ°ŽæŽãã次ãã§ç¡«é žãããªãŠã äž
ã§ä¹Ÿç¥ãããã溶åªãçå»ããç空äžã«èžçã
ãŠçŽç²ãªæ¶²äœ64ïœïŒåç89ïŒ ïŒãåŸãã沞ç¹79
ã81âïŒ20mmHgã ïœ ïŒïŒïŒïŒâãžã¡ãã«ïŒâïŒâãã㫠âïŒ
âãïŒâïŒïŒâãã³ãžã«ãªãã·ã«ã«ããã«ãªã
ã·âïŒâã€ã³ããªã«ïŒâïŒâãã³ãžã«ãªãã·ã«
ã«ããã«ã¢ããâããããªãã«ãªãã·ãã¢ã»ã
ãŒã âïŒâïŒïŒâãã³ãžã«ãªãã·ã«ã«ããã«ãªã
ã·âïŒâã€ã³ããªã«ïŒâïŒâãã³ãžã«ãªãã·ã«ã«
ããã«ã¢ããâããããªã³é ž50ïœïŒ0.1ã¢ã«ïŒããž
ã·ã¯ãããã·ã«ã¢ãã³20mlïŒ0.1ã¢ã«ïŒãæ²åãã
ãªãŠã ïŒïœãã¯ããé ¢é žïŒïŒïŒïŒâãžã¡ãã«ïŒâ
ïŒâããã«17.75ïœïŒ0.1ã¢ã«ïŒåã³ãžã¡ãã«ãã«
ã ã¢ãã300mlã®æ··åç©ã20æéæ¹æããå®æœäŸ
1bïŒã«åŸã€ãŠåŠçãããç²çæç©ãå±é溶åªãš
ããŠãã«ãšã³âãšãŒãã«ïŒïŒïŒïŒïŒãçšããã·ãª
ã«ã²ã«ã¯ãããã°ã©ãã€ãŒã«ãã粟補ããŠãçŽç²
ãªãªã€ã«ãåç76ïŒ ã§åŸããããã¯çš®ã ã®ç³»ã«ã
ããããŒãŒã«ã²ã«äžã®TLCã«ãããŠåäžã®ã¹ã
ãããæããŠãããRfïŒ0.6ïŒã¯ãããã«ã 70ã
ãšã¿ããŒã«30åã³è»é žïŒãããªãæ··åç©ïŒããαã
ïŒïŒ â7.28ãïŒïŒ£ïŒïŒïŒ ããšã¿ããŒã«ïŒ ïœ ïŒïŒïŒïŒâãžã¡ãã«ïŒâïŒâãã㫠âïŒ
âãïŒâïŒïŒâããããã·âïŒâã€ã³ããªã«ïŒ
âïŒâã¢ããâããããªãã«ãªãã·ãã¢ã»ããŒ
ã 倧æ°å§äžäžèšã§åŸãããååç©48ïœããïŒïŒ ã
ã©ãžãŠã âççŽ 2.5ïœã®ååšäžã€ãœãããããŒã«
ïŒäžã§æ°ŽçŽ æ·»å ãããçè«éã®æ°ŽçŽ ãåžåãã
ãæã觊åªãå»ããèžçºä¹Ÿåºããé ¢é žãšãã«ã§
æœåºããæ°ŽæŽããã溶åªãçå»åŸãæ®æž£ããã³ãŒ
ã³ã§åçµæ¶ããŠãçœè²çµæ¶14.5ïœïŒåç53ïŒ ïŒã
åŸããèç¹106ã107âããαãïŒïŒ ïŒïŒ7.48ãïŒïŒ£ïŒ
ïŒïŒ ãã¢ã»ãã³ïŒ å®æœäŸ 15 ïŒâã¢ããã³ãã«âã¡ãã« ïŒâãïŒâïŒïŒâ
ããããã·âïŒâã€ã³ããªã«ïŒïŒâïŒâã¢ãã
âããããªãã«ãªãã·ãã¢ã»ããŒã ãäžè¬åŒïŒïŒã
ãåŒãã
ïœ ïŒâã¢ããã³ãã«âã¡ã㫠âïŒâãïŒâ
ïŒïŒâãã³ãžã«ãªãã·ã«ã«ããã«ãªãã·âïŒâ
ã€ã³ããªã«ïŒâïŒâãã³ãžã«ãªãã·ã«ã«ããã«
ã¢ããâããããªãã«ãªãã·ãã¢ã»ããŒã âïŒâïŒïŒâãã³ãžã«ãªãã·ã«ã«ããã«ãªã
ã·âïŒâã€ã³ããªã«ïŒâïŒâãã³ãžã«ãªãã·ã«ã«
ããã«ã¢ããâããããªã³é ž50ïœïŒ0.1ã¢ã«ïŒããž
ã·ã¯ãããã·ã«ã¢ãã³20mlïŒ0.1ã¢ã«ïŒãæ²åãã
ãªãŠã ïŒïœãã¯ããé ¢é žïŒâã¢ããã³ãã«âã¡ã
ã«24.3ïœãåã³ãžã¡ãã«ãã«ã ã¢ãã500mlã®æ··
åç©ãåžžæž©ã§20æéæ¹æããå®æœäŸ1bïŒã«åŸã€
ãŠåŠçãããç²çæç©ã溶åºæº¶åªãšããŠãã«ãšã³
âãšãŒãã«ãçšããã·ãªã«ã²ã«ã¯ãããã°ã©ãã€
ãŒã«ãã粟補ããŠãçŽç²ãªçæç©ãåç77ïŒ ã§åŸ
ããããã¯éåžžã®ç³»ã«ãããã·ãªã«ã²ã«TLCã«
ãããŠåäžã®ã¹ããããæããŠããããαãïŒïŒ ïŒâ
ïŒãïŒïŒ£ïŒïŒïŒ ããšã¿ããŒã«ïŒ ïœ ïŒâã¢ããã³ãã«âã¡ã㫠âïŒâãïŒâ
ïŒïŒâããããã·âïŒâã€ã³ããªã«ïŒâïŒâã¢
ããâããããªãã«ãªãã·ãã¢ã»ããŒã 倧æ°å§äžäžèšã§åŸãããååç©36ïœããïŒïŒ ã
ã©ãžãŠã âççŽ 2.5ïœã®ååšäžã€ãœãããããŒã«
600mläžã§æ°ŽçŽ æ·»å ãããçè«éã®æ°ŽçŽ ãåžåã
ããæã觊åªãå»ãã溶åªãçå»ããé ¢é žãšã
ã«ã§æœåºãããæ°ŽæŽåŸãææã§åŠçããèžçºä¹Ÿåº
ããããã³ãŒã³äžã§åçµæ¶ããŠçæç©ãåç68ïŒ
ã§åŸããèç¹134âããαãïŒïŒ ïŒâ0.7ãïŒïŒ£ïŒïŒ
ïŒ ããšã¿ããŒã«ïŒãâ26.1ãïŒïŒ£ïŒïŒïŒ ãã¢ã»ã
ã³ïŒ å®æœäŸ 16 ïŒâã¢ããã³ã㫠âïŒâãïŒâïŒïŒâãã
ããã·âïŒâã€ã³ããªã«ïŒâïŒâã¢ããâãã
ããªãã«ãªãã·ãã¢ã»ããŒã ãäžè¬åŒïŒïŒã
ïŒïŒâãã³ãžã«ãªãã·ã«ã«ããã«ãªãã·âïŒâ
ã€ã³ããªã«ïŒâïŒâãã³ãžã«ãªãã·ã«ã«ããã«
ã¢ããâããããªãã«ãªãã·ãã¢ã»ããŒã âïŒâïŒïŒâãã³ãžã«ãªãã·ã«ã«ããã«ãªã
ã·âïŒâã€ã³ããªã«ïŒâïŒâãã³ãžã«ãªãã·ã«ã«
ããã«ã¢ããâããããªã³é ž50ïœïŒ0.1ã¢ã«ïŒããž
ã·ã¯ãããã·ã«ã¢ãã³20mlïŒ0.1ã¢ã«ïŒãæ²åãã
ãªãŠã ïŒïœãã¯ããé ¢é žïŒâã¢ããã³ãã«âã¡ã
ã«24.3ïœãåã³ãžã¡ãã«ãã«ã ã¢ãã500mlã®æ··
åç©ãåžžæž©ã§20æéæ¹æããå®æœäŸ1bïŒã«åŸã€
ãŠåŠçãããç²çæç©ã溶åºæº¶åªãšããŠãã«ãšã³
âãšãŒãã«ãçšããã·ãªã«ã²ã«ã¯ãããã°ã©ãã€
ãŒã«ãã粟補ããŠãçŽç²ãªçæç©ãåç77ïŒ ã§åŸ
ããããã¯éåžžã®ç³»ã«ãããã·ãªã«ã²ã«TLCã«
ãããŠåäžã®ã¹ããããæããŠããããαãïŒïŒ ïŒâ
ïŒãïŒïŒ£ïŒïŒïŒ ããšã¿ããŒã«ïŒ ïœ ïŒâã¢ããã³ãã«âã¡ã㫠âïŒâãïŒâ
ïŒïŒâããããã·âïŒâã€ã³ããªã«ïŒâïŒâã¢
ããâããããªãã«ãªãã·ãã¢ã»ããŒã 倧æ°å§äžäžèšã§åŸãããååç©36ïœããïŒïŒ ã
ã©ãžãŠã âççŽ 2.5ïœã®ååšäžã€ãœãããããŒã«
600mläžã§æ°ŽçŽ æ·»å ãããçè«éã®æ°ŽçŽ ãåžåã
ããæã觊åªãå»ãã溶åªãçå»ããé ¢é žãšã
ã«ã§æœåºãããæ°ŽæŽåŸãææã§åŠçããèžçºä¹Ÿåº
ããããã³ãŒã³äžã§åçµæ¶ããŠçæç©ãåç68ïŒ
ã§åŸããèç¹134âããαãïŒïŒ ïŒâ0.7ãïŒïŒ£ïŒïŒ
ïŒ ããšã¿ããŒã«ïŒãâ26.1ãïŒïŒ£ïŒïŒïŒ ãã¢ã»ã
ã³ïŒ å®æœäŸ 16 ïŒâã¢ããã³ã㫠âïŒâãïŒâïŒïŒâãã
ããã·âïŒâã€ã³ããªã«ïŒâïŒâã¢ããâãã
ããªãã«ãªãã·ãã¢ã»ããŒã ãäžè¬åŒïŒïŒã
æ¬çºæã®ååç©ã¯ãç¹ã«äžæ¢ç¥çµç³»ã«ãããŠé¡
èãªè¬ç掻æ§ãçºæ®ãããäžèšç¬¬ïŒè¡šã¯ãã©ãã
ã®è³ã«ãããçäœå ã»ãããã³ã®çååŠçæ€å®ã
ãŸãšãããã®ã§ããããããã®æ€å®ã¯ããŠã€ã¹ã¿
ãŒç³»éæ§æã©ããã«10mgïŒKgã®æäžéã§ïŒåçµå£
æäžããåŸã«å®æœããã è©Šè¬æ³ã¯æ¬¡ã®éãã§ããã ååç©ã®æäž æ¬çºæååç©ãèžçæ°ŽïŒPH5.2ïŒã«æº¶è§£åã¯è¯
ãåæ£ãããããã€ãã®ååç©ã¯ããé žæ§ã®åªäœ
äžã«æº¶è§£ãããæäžã¯ãé©åœãªã«ããŠãŒã¬ãçšã
ãŠçµå£ã§è¡ãªã€ãã次ãã§ãåç©ãå± æ®ºåïŒæé
ã±ãŒãžã«å ¥ããã è³è©Šæã®æ¡å åç©ããã®ããã³ãçšããŠæé ã«ããå± æ®ºã
ããè³ããã°ããååºããéã®åŸéšïŒposterior
part at the obex levelïŒã§åæãããæ£äžã®çžŠ
ã®åæãããŠïŒåã®åãååã®è³ãåŸããå·Šã®å
åã®è³ã秀éããããã«äžèšã®çååŠçæ¹æ³ã«çš
ããã çååŠçæ¹æ³ è³çµç¹ãïŒmlã®ãšã¿ããŒã«ïŒæ°ŽïŒ74ïŒ16ã
volïŒvolïŒäžã§ãã¢ãžãã€ã¶ãŒãçšããŠãã¢ãžã
ã€ãºãã次ãã§12æéãâ30âã«çœ®ãããé å¿å
解åŸãäžæž ãç容éã®æ°Žã«å ãã溶液ã®PHã6.1
ã«èª¿æŽããã次ãã§ãã»ãããã³ïŒïŒâHTïŒã
ã¢ã³ããŒã©ã€ãCG50ïŒ200ã400ã¡ãã·ãŠãããŒ
ã ã¢ã³ã ããŒã¹ç€Ÿè£œïŒã€ãªã³äº€æã«ã©ã äžã§
åé¢ãããã«ã©ã ãïŒmlã®æ°Žã§æŽæµããïŒmlã®
3N HClã§æº¶åºããã溶åºæ¶²ãPHïŒã«èª¿æŽããïŒ
âHTPãçµåããããŠãšãã¯ã¹AG50W4ïŒããŠ
ã±ãã«ã«ç€Ÿè£œïŒã«ã©ã ã«ç§»ããããã®ã¢ããé žã¯
ïŒmlã®0.2Né ¢é žãããªãŠã ã§æº¶åºãããæåŸ
ã«ãããŠãšãã¯ã¹ã«ã©ã ã溶åºãã溶åºæ¶²ãïŒâ
ããããã·ã€ã³ããŒã«é ¢é žïŒïŒâHIAAïŒãçµå
ããã»ãã¢ããã¯ã¹G10ïŒãã¢ã«ãã·ã¢ç€Ÿè£œïŒã«
ã©ã ã«ç§»ãããïŒâHTãïŒâHTPåã³ïŒâ
HIAAã®éã¯ãã«ãŒãŸã³ãšã°ãªãŒã³ã®è¢å ã¹ãã¯
ãã«æ³å³ã¡ã·ã¹ãã€ã³ã®ååšäžã«ã€ã³ããŒã«æ žãš
ãªã«ãœãã¿ãžã¢ã«ããããšã®éã§è¢å æ§ã®ã³ã³ã
ã¬ãã¯ã¹ãçæããããšãããªãæ¹æ³ã«ãã枬å®
ãããããããŠåŸãããå€ã¯ãå éšæšæºãçšããŠ
å段éæ¯ã®åçãèæ ®ããŠè£æ£ããããããã®å
çã¯ãïŒâHTåã³ïŒâHTPã«ã€ããŠã¯80ïŒ çšåºŠ
ã§ãïŒâHIAAã«ã€ããŠã¯75ïŒ çšåºŠã§ãã€ãã
èãªè¬ç掻æ§ãçºæ®ãããäžèšç¬¬ïŒè¡šã¯ãã©ãã
ã®è³ã«ãããçäœå ã»ãããã³ã®çååŠçæ€å®ã
ãŸãšãããã®ã§ããããããã®æ€å®ã¯ããŠã€ã¹ã¿
ãŒç³»éæ§æã©ããã«10mgïŒKgã®æäžéã§ïŒåçµå£
æäžããåŸã«å®æœããã è©Šè¬æ³ã¯æ¬¡ã®éãã§ããã ååç©ã®æäž æ¬çºæååç©ãèžçæ°ŽïŒPH5.2ïŒã«æº¶è§£åã¯è¯
ãåæ£ãããããã€ãã®ååç©ã¯ããé žæ§ã®åªäœ
äžã«æº¶è§£ãããæäžã¯ãé©åœãªã«ããŠãŒã¬ãçšã
ãŠçµå£ã§è¡ãªã€ãã次ãã§ãåç©ãå± æ®ºåïŒæé
ã±ãŒãžã«å ¥ããã è³è©Šæã®æ¡å åç©ããã®ããã³ãçšããŠæé ã«ããå± æ®ºã
ããè³ããã°ããååºããéã®åŸéšïŒposterior
part at the obex levelïŒã§åæãããæ£äžã®çžŠ
ã®åæãããŠïŒåã®åãååã®è³ãåŸããå·Šã®å
åã®è³ã秀éããããã«äžèšã®çååŠçæ¹æ³ã«çš
ããã çååŠçæ¹æ³ è³çµç¹ãïŒmlã®ãšã¿ããŒã«ïŒæ°ŽïŒ74ïŒ16ã
volïŒvolïŒäžã§ãã¢ãžãã€ã¶ãŒãçšããŠãã¢ãžã
ã€ãºãã次ãã§12æéãâ30âã«çœ®ãããé å¿å
解åŸãäžæž ãç容éã®æ°Žã«å ãã溶液ã®PHã6.1
ã«èª¿æŽããã次ãã§ãã»ãããã³ïŒïŒâHTïŒã
ã¢ã³ããŒã©ã€ãCG50ïŒ200ã400ã¡ãã·ãŠãããŒ
ã ã¢ã³ã ããŒã¹ç€Ÿè£œïŒã€ãªã³äº€æã«ã©ã äžã§
åé¢ãããã«ã©ã ãïŒmlã®æ°Žã§æŽæµããïŒmlã®
3N HClã§æº¶åºããã溶åºæ¶²ãPHïŒã«èª¿æŽããïŒ
âHTPãçµåããããŠãšãã¯ã¹AG50W4ïŒããŠ
ã±ãã«ã«ç€Ÿè£œïŒã«ã©ã ã«ç§»ããããã®ã¢ããé žã¯
ïŒmlã®0.2Né ¢é žãããªãŠã ã§æº¶åºãããæåŸ
ã«ãããŠãšãã¯ã¹ã«ã©ã ã溶åºãã溶åºæ¶²ãïŒâ
ããããã·ã€ã³ããŒã«é ¢é žïŒïŒâHIAAïŒãçµå
ããã»ãã¢ããã¯ã¹G10ïŒãã¢ã«ãã·ã¢ç€Ÿè£œïŒã«
ã©ã ã«ç§»ãããïŒâHTãïŒâHTPåã³ïŒâ
HIAAã®éã¯ãã«ãŒãŸã³ãšã°ãªãŒã³ã®è¢å ã¹ãã¯
ãã«æ³å³ã¡ã·ã¹ãã€ã³ã®ååšäžã«ã€ã³ããŒã«æ žãš
ãªã«ãœãã¿ãžã¢ã«ããããšã®éã§è¢å æ§ã®ã³ã³ã
ã¬ãã¯ã¹ãçæããããšãããªãæ¹æ³ã«ãã枬å®
ãããããããŠåŸãããå€ã¯ãå éšæšæºãçšããŠ
å段éæ¯ã®åçãèæ ®ããŠè£æ£ããããããã®å
çã¯ãïŒâHTåã³ïŒâHTPã«ã€ããŠã¯80ïŒ çšåºŠ
ã§ãïŒâHIAAã«ã€ããŠã¯75ïŒ çšåºŠã§ãã€ãã
ãè¡šã
æ¬çºæã®ååç©ã®æŽ»æ§ã¯ïŒ¬âïŒâHTPã®ãã
ã«æ¯ãé¡èã«é«ãããšãç解ã§ããã ãæ¯æ§è©ŠéšïŒ æ¬çºæã®ååç©ã®ããŠã¹ã«ãããæ¥æ§æ¯æ§ã¯ã
âïŒâHTPã®ããã«æ¯ã極ããŠäœããæ¬çºæ
ååç©ã®LD50å€ã¯ãããã1250mgïŒKg以äžã§ã
ããããã«å¯ŸããŠïŒ¬âïŒâHTPã®LD50å€ïŒçµ
å£ïŒã¯700mgïŒKgã§ããã LD50å€ã¯ãããŠã¹ãçšããŠçµå£æäžã«ããã
ãªãããã€ãŒã«ãåã³ãŠã€ã«ã³ã¯ãœã³ã®æ¹æ³ïŒJ.
PharmaCol.Exp.Ther.1949ïŒ96ïŒ99ã113ïŒã«åŸ
ã€ãŠæž¬å®ãããçµæã第ïŒè¡šã«ç€ºãã
ã«æ¯ãé¡èã«é«ãããšãç解ã§ããã ãæ¯æ§è©ŠéšïŒ æ¬çºæã®ååç©ã®ããŠã¹ã«ãããæ¥æ§æ¯æ§ã¯ã
âïŒâHTPã®ããã«æ¯ã極ããŠäœããæ¬çºæ
ååç©ã®LD50å€ã¯ãããã1250mgïŒKg以äžã§ã
ããããã«å¯ŸããŠïŒ¬âïŒâHTPã®LD50å€ïŒçµ
å£ïŒã¯700mgïŒKgã§ããã LD50å€ã¯ãããŠã¹ãçšããŠçµå£æäžã«ããã
ãªãããã€ãŒã«ãåã³ãŠã€ã«ã³ã¯ãœã³ã®æ¹æ³ïŒJ.
PharmaCol.Exp.Ther.1949ïŒ96ïŒ99ã113ïŒã«åŸ
ã€ãŠæž¬å®ãããçµæã第ïŒè¡šã«ç€ºãã
ãè¡šã
æ¬çºæã®ïŒâãïŒâïŒïŒâã€ã³ããªã«ïŒâïŒâ
ã¢ããâããããªãã«ãªãã·ãé ¢é žèªå°äœåã³ã
ããã®è¬ççã«èš±å®¹ã§ããä»å å¡©ãããã«é©çšã
ãå Žåãæ人åã³12æ以äžã®åäŸã«å¯ŸããŠã粟ç¥
å»åŠäžã®æ²»çã®ããã«ã¯ãïŒæ¥åœãéåžž25ã100
mgãçµå£ã§æäžããããŸãç¥çµåŠäžã®é害ã®æ²»ç
ã®ããã«ã¯ãïŒæ¥åœãéåžž100ã500mgãçµå£ã§æ
äžãããããç æ°ã®çš®é¡åã³çšåºŠã«å¿ããŠæŽã«å€
éæäžããããšãã§ããã åç©ã«é©çšããå Žåããããã®å Žåã«æºããŠäœ
éã«å¿ããŠåæ§ã«æäžãããã
ã¢ããâããããªãã«ãªãã·ãé ¢é žèªå°äœåã³ã
ããã®è¬ççã«èš±å®¹ã§ããä»å å¡©ãããã«é©çšã
ãå Žåãæ人åã³12æ以äžã®åäŸã«å¯ŸããŠã粟ç¥
å»åŠäžã®æ²»çã®ããã«ã¯ãïŒæ¥åœãéåžž25ã100
mgãçµå£ã§æäžããããŸãç¥çµåŠäžã®é害ã®æ²»ç
ã®ããã«ã¯ãïŒæ¥åœãéåžž100ã500mgãçµå£ã§æ
äžãããããç æ°ã®çš®é¡åã³çšåºŠã«å¿ããŠæŽã«å€
éæäžããããšãã§ããã åç©ã«é©çšããå Žåããããã®å Žåã«æºããŠäœ
éã«å¿ããŠåæ§ã«æäžãããã
Claims (1)
- ãç¹èš±è«æ±ã®ç¯å²ã ïŒ äžè¬åŒ ãåŒäžãã¯æ°ŽçŽ ååãçŽéè¥ããã¯åæç¶ã®
ççŽ æ°ïŒã12åã®ã¢ã«ãã«åºåã¯ã¡ãã¬ã³åºãçµ
åããããšã®ããççŽ æ°ïŒã16åã®åèç°è¥ãã
ã¯å€èç°çåæ°ŽçŽ åºã瀺ããã ã§è¡šããããïŒâãïŒâïŒïŒâã€ã³ããªã«ïŒâïŒ
âã¢ããâããããªãã«ãªãã·ãé ¢é žèªå°äœåã³
ãããã®è¬ççã«èš±å®¹ã§ããä»å å¡©ã ïŒ ïŒ€ïŒïŒ¬âäœã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé ã«èš
èŒã®ååç©ã ïŒ ïŒ¬âäœã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé ã«èšèŒã®
ååç©ã ïŒ ãšã㫠ïŒïŒ¬âïŒâãïŒâïŒïŒâãããã
ã·âïŒâã€ã³ããªã«ïŒâïŒâã¢ããâããããªã
ã«ãªãã·ãé ¢é žããã㫠ïŒïŒ¬âïŒâãïŒâ
ïŒïŒâããããã·âïŒâã€ã³ããªã«ïŒâïŒâã¢ã
ãâããããªãã«ãªãã·ãé ¢é žããªã¯ã㫠ïŒ
âïŒâãïŒâïŒïŒâããããã·âïŒâã€ã³ããª
ã«ïŒâïŒâã¢ããâããããªãã«ãªãã·ãé ¢é žå
ã³ããã·ã« ïŒïŒ¬âïŒâãïŒâïŒïŒâãããã
ã·âïŒâã€ã³ããªã«ïŒâïŒâã¢ããâããããªã
ã«ãªãã·ãé ¢é žãããªã矀ããéžã°ããç¹èš±è«æ±
ã®ç¯å²ç¬¬ïŒé ã«èšèŒã®ååç©ã ïŒ ã¡ã㫠âïŒâãïŒâïŒïŒâããããã·â
ïŒâã€ã³ããªã«ïŒâïŒâã¢ããâããããªãã«ãª
ãã·ãé ¢é žããšã㫠âïŒâãïŒâïŒïŒâãã
ããã·âïŒâã€ã³ããªã«ïŒâïŒâã¢ããâããã
ãªãã«ãªãã·ãé ¢é žãïœâããã㫠âïŒâ
ãïŒâïŒïŒâããããã·âïŒâã€ã³ããªã«ïŒâïŒ
âã¢ããâããããªãã«ãªãã·ãé ¢é žãïœâãã
㫠âïŒâãïŒâïŒïŒâããããã·âïŒâã€ã³
ããªã«ïŒâïŒâã¢ããâããããªãã«ãªãã·ãé ¢
é žãïœâãã³ã㫠âïŒâãïŒâïŒïŒâããã
ãã·âïŒâã€ã³ããªã«ïŒâïŒâã¢ããâããããª
ãã«ãªãã·ãé ¢é žãïœâããã·ã« âïŒâãïŒ
âïŒïŒâããããã·âïŒâã€ã³ããªã«ïŒâïŒâã¢
ããâããããªãã«ãªãã·ãé ¢é žãïœâãããã«
âïŒâïŒïŒâïŒïŒâããããã·âïŒâã€ã³ã
ãªã«ïŒâïŒâã¢ããâããããªãã«ãªãã·ãé ¢
é žãïœâãªã¯ã㫠âïŒâãïŒâïŒïŒâããã
ãã·âïŒâã€ã³ããªã«ïŒâïŒâã¢ããâããããª
ãã«ãªãã·ãé ¢é žãïœâããã·ã« âïŒâãïŒ
âïŒïŒâããããã·âïŒâã€ã³ããªã«ïŒâïŒâã¢
ããâããããªãã«ãªãã·ãé ¢é žãïŒïŒïŒïŒâãž
ã¡ãã«ïŒâïŒâãã㫠âïŒâãïŒâïŒïŒâã
ãããã·âïŒâã€ã³ããªã«ïŒâã¢ããâããããª
ãã«ãªãã·ãé ¢é žãïŒâã¢ããã³ãã«âã¡ãã«
âïŒâãïŒâïŒïŒâããããã·âïŒâã€ã³ããª
ã«ïŒâïŒâã¢ããâããããªãã«ãªãã·ãé ¢é žã
ïŒâã¢ããã³ã㫠âïŒâãïŒâïŒïŒâããã
ãã·âïŒâã€ã³ããªã«ïŒâïŒâã¢ããâããããª
ãã«ãªãã·ãé ¢é žåã³ïŒ¬âïŒâãïŒâïŒïŒâãã
ããã·âïŒâã€ã³ããªã«ïŒâïŒâã¢ããâããã
ãªãã«ãªãã·ãé ¢é žãããªã矀ããéžã°ããç¹èš±
è«æ±ã®ç¯å²ç¬¬ïŒé ã«èšèŒã®ååç©ã ïŒ äžè¬åŒ ã§è¡šããããé žã®ããšããŒã«åºåã³ïŒåã¯ïŒã¢ã
ãåºãR2OCOâåºãåŒäžãR2ã¯è³éŠæåºãæã
ãããšã®ããèèªæåã¯è³éŠæä¿è·åºã瀺ããã
ã§ä¿è·ããåŸãâCH2COORãåŒäžãã¯ãã
ã²ã³ååã瀺ããã¯æ°ŽçŽ ååãçŽéè¥ããã¯å
æç¶ã®ççŽ æ°ïŒã12åã®ã¢ã«ãã«åºåã¯ã¡ãã¬ã³
åºãçµåããããšã®ããççŽ æ°ïŒã16åã®åèç°
è¥ããã¯å€èç°çåæ°ŽçŽ åºã瀺ããããšåå¿ãã
ãšã¹ãã«åãã次ãã§è±ä¿è·ããããšãç¹åŸŽãšã
ãäžè¬åŒ ã§è¡šããããïŒâãïŒâïŒïŒâã€ã³ããªã«ïŒâïŒ
âã¢ããâããããªãã«ãªãã·ãé ¢é žèªå°äœåã³
ãããã®è¬ççã«èš±å®¹ã§ããä»å å¡©ã®è£œé æ¹æ³ã ïŒ ClCH2COORåã¯BrCH2COORãåŒäžãã¯
åèšã«åããããçšããŠãšã¹ãã«åããç¹èš±è«æ±
ã®ç¯å²ç¬¬ïŒèšèŒã®è£œé æ¹æ³ã ïŒ ïŒžâCOOR2ãåŒäžãããã³R2ã¯åèšã«å
ããããçšããŠããšããŒã«åºåã³ïŒåã¯ïŒã¢ãã
åºãä¿è·ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé åã¯ïŒé ã«èš
èŒã®è£œé æ¹æ³ã ïŒ ïŒâïŒïŒâããããã·âïŒâã€ã³ããªã«ïŒé ž
èªå°äœãšä¿è·è©Šè¬ïŒžâCOOR2ãåŒäžãåã³R2
ã¯åèšã«åããããšã®çž®åããããã²ã³åæ°ŽçŽ é ž
ã®å容äœã§ããå¡©åºã®ååšäžãéãããã³æ§æº¶åª
äžã§è¡ãªãç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé åã¯ïŒé ã«èšèŒ
ã®è£œé æ¹æ³ã ïŒïŒ éãããã³æ§æº¶åªããžã¡ãã«ãã«ã ã¢ãã
ã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé ã«èšèŒã®è£œé æ¹æ³ã ïŒïŒ ã¢ããåºåã³ïŒåã¯ïŒæ°Žé žåºã®è±ä¿è·ãæ¥
觊éå ã«ãã€ãŠè¡ãªãç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé ã«èš
èŒã®è£œé æ¹æ³ã ïŒïŒ äžè¬åŒ ãåŒäžãã¯æ°ŽçŽ ååãçŽéè¥ããã¯åæç¶ã®
ççŽ æ°ïŒã12åã®ã¢ã«ãã«åºåã¯ã¡ãã¬ã³åºãçµ
åããããšã®ããççŽ æ°ïŒã16åã®åèç°è¥ãã
ã¯å€èç°çåæ°ŽçŽ åºã瀺ããã ã§è¡šããããïŒâãïŒâïŒïŒâã€ã³ããªã«ïŒâïŒ
âã¢ããâããããªãã«ãªãã·ãé ¢é žèªå°äœåã³
ãããã®è¬ççã«èš±å®¹ã§ããä»å å¡©ã®å°ãªããšã
ïŒçš®ãå«æããããåã³åç©çšè³å ã»ãããã³ã¬
ãã«å¢å è¬ã
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR8101931A FR2499076A1 (fr) | 1981-02-02 | 1981-02-02 | Nouveaux derives de l'acide ((indol-3 yl)-3 amino-2 propionyloxy)-2 acetique, procedes pour leur preparation et medicaments les contenant |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS57188566A JPS57188566A (en) | 1982-11-19 |
| JPS6136830B2 true JPS6136830B2 (ja) | 1986-08-20 |
Family
ID=9254719
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP57016176A Granted JPS57188566A (en) | 1981-02-02 | 1982-02-02 | 2-(3-(3-indolyl)-2-amino-propionyloxy)acetic acid derivative, manufacture and medicine containing same |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US4456611A (ja) |
| EP (1) | EP0057631B1 (ja) |
| JP (1) | JPS57188566A (ja) |
| AT (1) | ATE11912T1 (ja) |
| DE (2) | DE57631T1 (ja) |
| FR (1) | FR2499076A1 (ja) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2499076A1 (fr) * | 1981-02-02 | 1982-08-06 | Panmedica Laboratoires | Nouveaux derives de l'acide ((indol-3 yl)-3 amino-2 propionyloxy)-2 acetique, procedes pour leur preparation et medicaments les contenant |
| FR2531713A2 (fr) * | 1981-09-16 | 1984-02-17 | Panmedica Sa | Nouvelles compositions a base de 5-hydroxytryptophane, leur procede de preparation et medicaments les contenant |
| FR2546517B1 (fr) * | 1983-05-24 | 1987-04-24 | Panmedica | Nouveaux dipeptides du -l-5-hydroxy-tryptophane, procedes pour leur preparation et medicaments les contenant |
| US5079366A (en) * | 1987-04-07 | 1992-01-07 | University Of Florida | Quarternary pyridinium salts |
| US4888427A (en) * | 1987-04-07 | 1989-12-19 | University Of Florida | Amino acids containing dihydropyridine ring systems for site-specific delivery of peptides to the brain |
| US4822812A (en) * | 1987-05-21 | 1989-04-18 | Merrell Dow Pharmaceuticals Inc. | β-(Fluoromethylene)-5-hydroxytryptophan and derivatives and their use as prodrugs for MAO inhibition |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB873777A (en) * | 1959-01-26 | 1961-07-26 | Upjohn Co | 5-hydroxy-ª--alkyltryptophans |
| GB895034A (en) * | 1959-10-15 | 1962-04-26 | Caterpillar Tractor Co | Improvements in or relating to pipe-laying tractors |
| GB1080470A (en) * | 1963-12-31 | 1967-08-23 | Merck & Co Inc | Indole derivatives |
| IT1055518B (it) * | 1971-05-18 | 1982-01-11 | Rotta Research Lab | Derivatives del triptofano |
| US4000297A (en) * | 1971-05-18 | 1976-12-28 | Rotta Research Laboratorium S.P.A. | N-p-chlorobenzoyl tryptophane, salts and compositions thereof |
| DE2234651C3 (de) * | 1972-07-14 | 1978-11-09 | Troponwerke Gmbh & Co Kg, 5000 Koeln | Eckige Klammer auf l-(p-Chlorbenzoyl)-5-methoxy-2-methyl-3-indol] -acetoxj essigsaure, ihre Salze mit Basen, Verfahren zu ihrer Herstellung sowie pharmakologische Zubereitungen |
| US3988341A (en) * | 1974-06-25 | 1976-10-26 | Merck & Co., Inc. | Esterification process |
| DE2940373A1 (de) * | 1979-10-05 | 1981-04-23 | Troponwerke GmbH & Co KG, 5000 Köln | Lysin-(1-(p-chlorbenzoyl)-5-methoxy-2-methyl-3-indol) -acetoxy-acetate, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln |
| FR2499076A1 (fr) * | 1981-02-02 | 1982-08-06 | Panmedica Laboratoires | Nouveaux derives de l'acide ((indol-3 yl)-3 amino-2 propionyloxy)-2 acetique, procedes pour leur preparation et medicaments les contenant |
-
1981
- 1981-02-02 FR FR8101931A patent/FR2499076A1/fr active Granted
-
1982
- 1982-01-22 AT AT82400126T patent/ATE11912T1/de not_active IP Right Cessation
- 1982-01-22 EP EP82400126A patent/EP0057631B1/fr not_active Expired
- 1982-01-22 DE DE198282400126T patent/DE57631T1/de active Pending
- 1982-01-22 DE DE8282400126T patent/DE3262357D1/de not_active Expired
- 1982-01-26 US US06/342,929 patent/US4456611A/en not_active Expired - Fee Related
- 1982-02-02 JP JP57016176A patent/JPS57188566A/ja active Granted
-
1984
- 1984-03-07 US US06/587,043 patent/US4568754A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| FR2499076A1 (fr) | 1982-08-06 |
| EP0057631A1 (fr) | 1982-08-11 |
| JPS57188566A (en) | 1982-11-19 |
| US4568754A (en) | 1986-02-04 |
| US4456611A (en) | 1984-06-26 |
| DE3262357D1 (en) | 1985-03-28 |
| DE57631T1 (de) | 1983-04-28 |
| FR2499076B1 (ja) | 1983-04-01 |
| EP0057631B1 (fr) | 1985-02-20 |
| ATE11912T1 (de) | 1985-03-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SU1272984A3 (ru) | СпПÑПб пПлÑÑеМО пÑПОзвПЎМÑÑ ÑÑалазОМ-4-Ол-ÑкÑÑÑМПй кОÑлПÑÑ ÐžÐ»Ðž ÐžÑ ÑПлей | |
| FR2530626A1 (fr) | Composes de carbostyryle | |
| EP0432040A1 (fr) | Dérivés hétérocycliques d'acylaminothiazoles, leur préparation et compositions pharmaceutiques en contenant | |
| BG61605B1 (bg) | ÐеÑПЎ за пПлÑÑаваМе Ма ÑПÑЌПÑеÑПл О ÑÑÐµÐŽÐžÐœÐµÐœÐžÑ ÐŸÑ ÑÑÑаÑагÑÑпа | |
| HU226777B1 (en) | Method of preparing delta-9-tetrahydrocannabinol esters | |
| KR850001228B1 (ko) | ì¹í ìžë늰-2-ìš ì ë첎ì ì ì¡°ë°©ë² | |
| US4134991A (en) | Derivatives of 2-(3-phenyl-2-aminopropionyloxy)-acetic acid | |
| JPS6136830B2 (ja) | ||
| JPH0139425B2 (ja) | ||
| AU722147B2 (en) | N-(benzothiazol-2-yl) piperidine-1-ethanamine derivatives, their preparation and application in therapeutics | |
| EP0074903B1 (fr) | Dérivés d'amino-2 tétrahydro-1,2,3,4 naphtalÚne, leur préparation et leur application en thérapeutique | |
| EP0337774B1 (en) | CCK antagonists | |
| DE69029198T2 (de) | Cholecystokinin-antagonisten | |
| EP0062919B1 (de) | Neue Indol-Derivate, Verfahren zu ihrer Herstellung und pharmazeutische PrÀparate, die diese Verbindungen enthalten | |
| JP2004529982A (ja) | éæµçã«æå¹ãªæ°èŠãªååç© | |
| FR2479830A1 (fr) | Nouveaux derives de l'indolobenzoxazine, leurs sels, procede de preparation, application a titre de medicaments et compositions les renfermant | |
| CA2012569A1 (en) | Benzothiopyranylamines | |
| EP1511728B1 (fr) | Derives d oxophenyl-cyclohexyl-propanolamine, leur preparati on et leur application en therapeutique | |
| FR2584070A1 (fr) | Nouveaux derives de l'hydroxy alkoxy 4-phenyl propyl indole, leurs sels, procede et intermediaires de preparation, application a titre de medicaments et compositions les renfermant. | |
| JP2967231B2 (ja) | ïŒïŒïŒâãã¢ãžã³èªå°äœ | |
| WO1999062865A1 (en) | Haloethyl-2-[ (2,6-dichlorophenyl) amino] phenylacetoxyacetate derivatives and their use as an intermediate to synthesize aceclofenac | |
| CH620678A5 (en) | Process for the preparation of a derivative of piperidine | |
| JPH01250353A (ja) | ïŒâã¢ã·ã«ã¢ããâããã©ãããã¢ã¯ãªãžã³èªå°äœåã³è©²èªå°äœãæå¹æåãšããèšæ¶é害æ¹åå€ | |
| CS200172B2 (cs) | Způsob pÅÃpravy derivátů oÅ-methyl-3,4-dihydroxyfenylalaninu | |
| US20050131053A1 (en) | Indole derivatives substituted with long-chain alcolhols and medicaments containing them |